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Follicles are the functional units of the ovary and are composed of a germ cell (the oocyte) and 
layers of somatic cells (granulosa and theca cells). The ovaries contain a limited number of 
immature follicles. Serving as the ovarian reserve, follicles have the potential to develop and 
produce mature oocytes capable of fertilization in a highly regulated process called 
folliculogenesis. Chemo- and radiation therapies used as cancer treatments can have unintended 
effects on patients such as detrimental effects on the non-replenishable ovarian reserve, resulting 
primary ovarian insufficiency (POI) and/or infertility. Clinically established fertility preservation 
methods, such as egg and embryo cryopreservation, are not applicable to all patients. This gap 
has motivated the development of new strategies to produce mature oocytes to restore fertility at 
a later date. Among the emerging technologies, in vitro ovarian follicle growth (IVFG) systems 
represent great translational potentials to harvest fertilizable eggs regardless of patients’ age or 
hormone stimulation. Isolated single follicles can be cultured in two-dimensional (2D) or three-
dimensional (3D) systems. Specifically among 3D methods, encapsulated in vitro follicle growth 
(eIVFG) systems have been developed to mimic the native 3D physiological environment of the 
ovaries by maintaining a spherical morphology and the cell-cell and cell-matrix interactions 
between the oocyte and somatic cells of the follicle.  
 
To better understand reflect various signals (growth factors, hormones, extracellular matrixes, 
mechanics, etc.) in the culture environment, we investigated multiple aspects of the eIVFG 
environment to provide guiding principles to facilitate the development of alternative fertility 
preservation options. We first started with secondary follicles that can autonomously grow in 
vitro and examined the effects of xenobiotics on developing follicles in vitro. This knowledge 
not only complemented our current understanding of the toxicity of chemotherapy drugs and 
environmental toxicants. More importantly, the application of such a high-throughput eIVFG 
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system together with its dynamic culture environment provides a faster and cheaper alternative 
toxicity evaluation method compared to traditional animal models. Next, we examined the 
interactions between small, early stage (late primary and early secondary) follicles and 
supporting stromal cells. By allowing such interactions in our novel biomimetic matrix, we were 
able to harvest mature, fertilizable oocytes from small follicles. Additionally, by using 
supporting cells derived in a patient-specific way, this synthetic and xeno-free matrix represents 
great translational potentials for clinical application. Lastly, we examined the paracrine cues 
present in various culture environments by monitoring the dynamic activities of specific 
transcription factors (TFs) in real time. For the first time ever lentiviral transduction of the 
follicles, we delivered specific TF reporters. By quantifying bioluminescence intensity from the 
reporters, we investigated the underlying mechanism that results in a number-dependent manner 
of folliculogenesis. Additionally, this technique can serve as a powerful tool to probe potential 
TFs on a large scale. By quantifying in real time the dynamic activities of specific TFs, this 
technique can provide insightful knowledge to the causation between TF activities and 
phenotypical changes.  
 
In conclusion, by examining multiple aspects of the in vitro ovarian follicle environment, this 
dissertation provides new understanding of the bioengineering principles in numerous in vitro 
follicle culture applications and in the field of reproductive biology more broadly. By providing 
novel solutions to ongoing clinical issues, the research described in this dissertation reveals a 








As the central organ in the female reproductive system, the ovary is responsible for producing 
healthy fertilizable oocytes. By secreting sex hormones, the ovary also serves as an important 
endocrine gland that links reproductive and non-reproductive organs in females to the timing of 
ovarian cycles. Ovaries are the sites where pluripotent epiblasts-like primordial germ cells 
(PGCs) differentiate to form follicles, develop and mature. Early in fetal life, the PGCs undergo 
a period of proliferation (mitosis). Following the initial proliferative stage, PGCs enter meiosis to 
differentiate into primary oocytes. Primary oocytes that are arrested at meiosis prophase I 
interact with ovarian somatic cells to form the primordial follicles during gestation (Anderson 
and Hirshfield 1992; Baillet and Mandon-Pepin 2012).  
 
Ovarian follicles are the functional and morphological units of the ovaries. They consist of a 
meiotically arrested germ cell (the oocyte) and multiple surrounding somatic cells (granulosa and 
theca cells) as well as a basement membrane (BM). In mammals, primordial follicles serve as a 
resting and finite pool of the most undeveloped oocytes available during the female reproductive 
life span (Edson et al. 2009). During postnatal development, groups of follicles are recruited as 
needed. Follicle recruitment is in general subdivided into 2 categories: the initial activation of 
primordial follicles throughout female reproductive life, and the cyclic recruitment after puberty 
of a limited number of small primary follicles from the growing cohorts, during which a subset 
of follicles are selected for dominance and ovulation (McGee and Hsueh 2000).  
 
Upon puberty, ovarian follicle development (folliculogenesis) is a highly orchestrated event by 
the timely coordination of the hypothalamus-pituitary-gland-gonad (HPG) axis (Fig. 1).  
Released from the hypothalamus, the gonadotropin releasing hormone (GnRH) circulates to the 
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anterior pituitary gland to stimulate the release of follicle stimulating hormone (FSH) and 
luteinizing hormone (LH). FSH induces the early growth of the ovarian follicles, but the final 
maturation requires LH as well. Development of ovarian follicles is usually characterized by: 1) 
growth of the primary oocyte; 2) proliferation of the granulosa cells; and 3) development of the 
theca cells (Moore et al. 2015). With mitotic expansion of granulosa cells, single-layered primary 
follicles are transformed into multi-layered secondary follicles (Oktem and Urman 2010). As 
follicles continue to increase in size, a single large fluid-filled cavity, called the antrum, is 
formed, serving as a vital and dynamic microenvironment for the oocyte and the follicular cells. 
At this stage, along with increased vascularization of the theca layer and proliferation of somatic 
cells, growing oocytes in antral follicles migrate asymmetrically to one side of the follicle, where 
they are surrounded by the cumulus granulosa cells. In response to LH and FSH, growing 
follicles also produce indispensable hormones, estradiol and progesterone, that regulate 
development and functions of female reproductive organs (Fig. 1). Stimulated by LH, theca cells 
produce androgen, which is then converted to estradiol by granulosa cells under the stimulation 
of FSH. Hormones produced by the follicles negatively feed back to the hypothalamus and 
anterior pituitary gland to maintain physiologically balanced endocrine functions. The LH surge 
also seems to induce resumption of the first meiotic division of primary oocytes, prompting the 
progression to mature secondary oocytes ready for fertilization (Wigglesworth et al. 2013). 
Throughout the progression of follicle development and maturation, bidirectional signaling is 
required between oocytes and the surrounding somatic cells (Burns et al. 2002). The oocyte 
serves as the dominant factor orchestrating the onset of folliculogenesis and regulating somatic 
cell proliferation and differentiation during follicular development (Knight and Glister 2006). 
Maintenance of oocyte meiotic arrest by the granulosa cells in return, is also indispensable for 
normal female fertility (Burns et al. 2002; Peng et al. 2013).  
 
To recapitulate the key events of folliculogenesis, various in vitro follicle culture systems have 
been established, such as on the traditional two-dimensional (2D) cell culture surfaces and 
encapsulated three-dimensional (3D) in vitro follicle growth (eIVFG) systems. It is beyond the 
scope of this dissertation to discuss in detail the 2D systems, which contributed to our knowledge 
of follicle biology, yet failed to successfully translate into larger species, including humans. On 
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the other hand, 3D culture systems more effectively simulate physiological conditions, providing 
essential support for the overall architecture of developing follicles in vitro.  
 
The first 3D eIVFG was based on alginate, which is a natural biopolymer and served as a tissue 
engineering scaffold for various applications (Drury and Mooney 2003; Kuo and Ma 2001; Lee 
and Mooney 2001). With low cytotoxicity, alginate is readily available and gels under gentle 
conditions with bivalent cations such as Ca2+. Because of its biocompatibility, alginate has been 
successfully used for follicle encapsulation and culture in vitro (J Xu et al. 2011; Xu et al. 2006). 
As follicle develops in vitro, alginate provides the necessary 3D structural support that mimics 
the environment of ovarian tissue while supporting somatic cells and their interactions with the 
oocyte to optimize oocyte development.  
 
The best results for the in vitro culture of ovarian follicles were demonstrated in low alginate 
concentrations (0.25% to 0.5%) for both mice (West-Farrell et al. 2009; E. R. West et al. 2007; 
Xu et al. 2006) and non-human primates (Jin et al. 2010; Xu et al. 2010), because alginate does 
not degrade at the same rate as follicles grow (Boontheekul et al. 2005). Low concentrations of 
alginate promote greater follicle survival, antrum formation, follicular growth, steroid secretion 
and resumption of meiosis compared to high concentrations (E. R. West et al. 2007). Despite of 
the success in mice and several large mammalian species, the translation of alginate work to 
human remains challenging. Human ovarian follicles require extended culture period and reach a 
much greater terminal size compared to other species (Telfer and Zelinski 2013), indicating that 
human ovarian follicle in vitro culture requires a dynamic cell-responsive environment (Qu et al. 
2015).  
 
To better engineer the in vitro ovarian follicle environment for human translation, this 
dissertation first started with secondary follicles, examining an already established dynamic 
eIVFG system in fibrin alginate and its application in in vitro toxicological testing. Various 
toxicants, drugs and their metabolites carry potential ovarian toxicity. Ovarian follicles are 
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susceptible to this type of damage at all stages of their development. In this part of the 
dissertation, we first demonstrated the usefulness of a hydrogel based 3-dimensional (3D) mouse 
ovarian follicle culture as a tool to study ovarian toxicity in a different setup. The 3D in vitro 
culture, based on fibrin alginate interpenetrating network (FA-IPN), preserves the architecture of 
the ovarian follicle and physiological structure-function relationship. The fibrin component in the 
system is degraded by plasmin and appears as a clear circle around the encapsulated follicle. The 
degradation area of the follicle is strongly correlated with follicle survival and growth. We then 
applied the novel 3D high-throughput (HTP) in vitro ovarian follicle culture system to study the 
ovotoxic effects of an anti-cancer drug, Doxorobucin (DXR) and mixtures of environmental 
toxicants such as 7,12-dimethylbenz[a]anthracene (DMBA) and lindane. We established 
concentration-dependent responses of follicles when exposed to selected toxicants and identified 
lethal concentrations of the tested toxicants that kill 10% and 50% of the population of cultured 
follicles (LC10s and LC50s).  
 
With the knowledge of secondary follicle development in vitro, the dissertation then moved on to 
investigate how to better support smaller follicles (late primary and early secondary) 
development in vitro with a translational approach for clinical application in fertility 
preservation. Contrary to alginate, poly-ethylene glycol (PEG) is a biocompatible synthetic 
polymer with tunable physical properties. Consequently, PEG hydrogels can be degraded by soly 
proteolysis, thus providing a xeno-free, cell-responsive scaffold for the co-encapsulation of 
mouse primary and early secondary ovarian follicles (80 – 120 μm) with mouse adipose derived 
stem cells (ADSCs). Similar to accepted approaches to utilize feeder cells to promote the 
undifferentiated growth of embryonic stem cells (ESCs), co-encapsulated ADSCs provide 
critical paracrine factors necessary for early-stage follicle survival and maturation. The dual-site 
crosslinker, YKNS/VPMS, significantly improved ADSCs survival compared to YKNS, which 
was previously used for multi-layer secondary follicle culture. More importantly, this enhanced 
PEG hydrogel culture significantly improved the survival and maturation of the early-stage 
follicles cultured in vitro. The use of the biocompatible and biodegradable PEG hydrogels offers 
a xeno-free culture system that could be used to culture large species and human follicles. 
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Moreover, ADSCs can be derived in a patient specific way in clinical settings, therefore making 
this approach highly translational. 
 
Lastly, to better understand how follicles interact with the in vitro environment, the dissertation 
investigated several critical transcription factors and their dynamic activities during 
folliculogenesis, providing insights to the development of the next generation of eIVFG systems. 
Multiple aspects of IVFG environments profoundly affect follicle development and maturation. 
Paracrine cues in the environment trigger intracellular signaling cascades that result in up- or 
down-regulation of transcription factors (TFs) – powerful players in follicle development. Recent 
studies have shown that culturing small follicles in groups of 10 (10X) or with support cells 
improves follicle survival, growth and maturation rates. However, little is known about the 
paracrine signaling mechanism and the identity of key TFs. We employed TRACER 
(Transcriptional Activity CEll aRrays) for continuous, real-time dynamic quantification of TF 
activity in mouse ovarian follicle cultured in alginate hydrogels. We evaluated the expression of 
4 TFs (p53, NF-κB, Gli, and HIF1) associated with follicle development at various stage in 
ovarian follicles cultured in groups of 5 (5X, controls) or 10 (10X). Our results demonstrated that 
distinct differential TF activities revealed potential mechanism underlying the different 
phenotypes in the 2 culture schemes. Combined with phenotype monitoring and hormone 
analysis, our approach captures the dynamics of TF activities in follicles cultured in different 
environments, identifying conserved paracrine signaling mechanisms under beneficial co-culture 
effects. 
 
Collectively, by examining different aspects of eIVFG and various eIVFG systems designed 
specifically for certain stages of follicles, this dissertation aims to provide novel insights to 
ongoing clinical issues. The research described in this dissertation also reveals a translational 





II. High-throughput (HTP) toxicology test system in 3-dimensional (3D) murine ovarian 
follicle culture 
Previously published as:  PloS one 10.10 (2015): e0140205. 
 
1. Introduction 
Ovaries are the central reproductive organs during the pre-pubescent and reproductive years. 
Ovarian follicle is the functional and morphological unit composed of the germ cell (the oocyte) 
and the surrounding somatic cells (theca and granulosa cells). The somatic cells produce 
hormones necessary for the regulation of the reproductive system, and communicate with the 
oocyte for its maintenance growth and development.  During the process of follicular growth, 
i.e., folliculogenesis, the cross-talk between the germ and somatic compartments enables the 
enclosed immature oocyte to develop into a mature fertilizable ovum. Xenobiotic exposure 
disrupting oocyte-to-somatic cells interaction can lead to deleterious effects on folliculogenesis, 
resulting in oocyte incompetence, genetic and epigenetic changes, and dis-regulated hormone 
production. Thus it would affect the reproductive system at different levels. Considering the 
finite number of undeveloped (primordial) follicles in mammalian females, any damage to the 
primordial follicle pool is irreversible and results in premature ovarian failure (Combes et al. 
2004; Hareng et al. 2005).  
 
Evaluation and prediction of potential reproductive toxicity is a public health priority. However, 
based on the requirements of the US Environmental Protection Agency and the European 
REACH program, a complete set of in vivo tests for a single chemical requires use of thousands 
of animals, making costs and time spent prohibitive (Vandenberg et al. 2012).   
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This difficulty has motivated the development of in vitro high-throughput (HTP) screening 
assays to prioritize chemicals for in-depth investigation (Miller et al. 2006; Symonds et al. 2006; 
Tomic et al. 2006). With few exceptions, cell based in vitro screening assays employ tissue 
culture plastic (TCP) as the standard substratum, which is easy to use, relatively inexpensive and 
has a long shelf life. Similar methods are used for in vitro screening assays for reproductive 
toxicology studies, where, mouse ovarian follicles are cultured on such TCP surfaces in a 2-
dimensional (2D) manner for an average of 72 hours with various toxicant exposure (Kreeger et 
al. 2005; Pangas et al. 2003). This approach is limited for short periods of toxicant exposure and 
non-physiological flattened deformed follicular phenotype (Hirshfield 1991; Miller et al. 2005) 
due to lack of 3D tissue support. Furthermore, 2D culture does not adequately replicate the 
physiologically relevant cellular microenvironment and therefore provides unreliable results 
(Kreeger et al. 2005; Pangas et al. 2003). Follicles are large 3-dimensional (3D) structures that 
significantly expand in volume during development. Under physiological conditions the oocyte 
is enclosed in a dense circle of somatic cells allowing them to communicate through transzonal 
projections (TZPs) that extend through the zona pellucida and connect with each other via gap 
junctions on the oocyte membrane (Melvin E Andersen and Daniel Krewski 2009).   
 
Deprived of the spatial support in traditional 2D cultures, the oocyte is disadvantaged by lacking 
the necessary crosstalk to somatic cells due to gap junction disruption and a fully exposed 
antrum. The antrum, a closed fluid-filled cavity under physiological conditions, develops nearby 
the oocyte as the follicle expands. Residing in the center of the avascular follicles, the expansion 
of the antrum and the formation of the follicular fluid within is a key indicator of follicular 
growth, which heralds the development of a follicle to pre-ovulatory stage. Molecules in the 
follicular fluid includes hyaluronan, chondroitin sulfate proteoglycan versican and inter-α-trypsin 
inhibitor, suggesting that the antrum is osmotically active (Clarke et al. 2006; Matti et al. 2010). 
In addition, the presence of antrum may serve as a buffering system, protecting follicles from 
abrupt changes in hormone concentrations or toxic exposure. On the contrary, in the non-
physiological setting of 2D cultures, the oocyte is not protected from sudden toxic exposures 




In this study we aimed to design a 3D system that allows both culturing follicles in in-vivo-like 
conditions and continuous morphological, genetic and biochemical sampling, using the 
previously reported fibrin-alginate interpenetrating network (FA-IPN) (Shikanov et al. 2009, 
2011b). FA-IPN is a dynamic culture system for in vitro follicle cultures. Naturally derived, 
alginate is slowly degrading and biologically inert to ovarian tissue. As such, it provides 
structural support for the follicles during the extended (10 to 12 days) culture period. Fibrin 
however, is a biologically active protein and degrades as follicles grow in response to follicle 
stimulating hormone (FSH). Fibrin degradation appears as a clear circle around the encapsulated 
follicle, increasing with the duration of culture. Importantly, if the follicle is damaged, fibrin 
degradation will significantly slow down or stop due to lack of the proteolytic activity normally 
carried out by proteases from functioning granulosa cells of a viable follicle (Shikanov et al. 
2009, 2011b). As a result, follicle health and survival can be correlated with the proteolytic 
activity by quantifying fibrin degradation, which serves as the base for the proposed system. 
 
Following initial design stage, we validated the system performance by exposing cultured 
follicles to doxorubicin (DXO), a moderately ovotoxic chemotherapeutic agent (Ben-Aharon et 
al. 2010). Follicles exposed to increasing doses of DXR demonstrated decreased survival rate, 
and decreased fibrin degradation. We utilized MATLAB®’s image processing toolbox to capture 
the changes in follicle dimensions and degradation of surrounding matrix. This approach allowed 
quantitative analysis of the effect of toxicants on folliculogenesis and to compare multiple 
conditions with variations in duration of exposure, toxicant types and/or concentration. 
 
2. Material and Methods 
All chemicals were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise specified. 
Media formulations were purchased from Invitrogen (Carlsbad, CA). Nalgin MV-120 sodium 
alginate (Carrageenan, Xanthan, Alginate, Ingredients Solution, Inc., Waldo, ME, USA) and the 
fibrinogen-thrombin kits (Baxter Healthcare, BioScience Division, Westlake Village, CA) were 





Mice were purchased (Harlan, Indianapolis, IN), and housed in ventilated cages in a temperature 
and light controlled environment (12L: 12D) and provided with food and water. Animals were 
treated in accordance with the guidelines and regulations set forth by the National Institutes of 
Health Guide for the Care and Use of Laboratory Animals and the established Institutional 
Animal Use and Care protocol at the University of Michigan. Experiments with animals were 
performed in strict accordance with the protocols approved by the Institutional Animal Care and 
Use Committee (IACUC) at the University of Michigan (PRO00004106). All experiments were 
performed under isofluorane anesthesia, and all efforts were made to minimize suffering. 
 
2.2 Follicle isolation, encapsulation and culture 
Two-layered secondary follicles ranging from 120 to 135 µm were mechanically isolated from 
ovaries of D12-D14 female F1 hybrids (C57BL/6JRccHsd inbred × CBA/J CrHsd) and were 
then encapsulated in 7.5 µL of fibrin alginate gel based on “the drop method” described by 
Shikanov et al. with modifications (Shikanov et al. 2011b). Briefly, the final fibrin alginate 
mixture consisted of 12.5 mg/mL fibrinogen and 0.2% (w/v) alginate while thrombin 
concentration was adjusted to 12.5 mg/mL. The cross-linking time for beads in thrombin/Ca2+ 
solution was 2 minutes. Encapsulated follicles were cultured in α-MEM based growth media 
(GM), supplemented with 1 mg/mL Fetuin, 3 mg/mL bovine serum albumin (BSA, MP 
Biomedicals, Irvine, CA), 0.1% insulin-transferrin-selenium (ITS), and 10 mIU/mL recombinant 
human follicle stimulating hormone (rhFSH, GONAL-f ® 75 IU, Merck Serono, S.A.). Every 2 
days, the cultured follicles were imaged by a light microscope (DMI 3000, Leica, Germany) with 
follicle diameters measured with the Leica software LAS V4.3 (Leica, Germany) while half (50 
µL) of the growth media was replaced by pre-equilibrated, fresh media. 
A stock solution of aprotinin was dissolved in DPBS and then diluted in growth media before 
media changing. In this study, we used aprotinin to control fibrin degradation and its 




2.3 Oocyte maturation 
After 12 days of culture, healthy follicles with diameters between 300 and 350 µm were 
identified. The alginate was degraded by placing the alginate beads with the follicles in 100 µL 
αMEM medium containing 1% fetal bovine serum (FBS) and 10 mIU/mL alginate lyase (MP 
Biomedicals, Irvine, CA) for 2 minutes at 37 ˚C and 5% CO2. After retrieving the follicles from 
the alginate beads, all the follicles were transferred to an IVF dish with maturation media 
composed of αMEM, 10% FBS, 5 ng/mL epithelial growth factor (EGF), 1.5 IU/mL human 
chorionic gonadotropin (hCG), and 10 mIU/ml rhFSH for 12-14 hours at 37 ˚C and 5% CO2. 
Oocytes were then denuded from the surrounding cumulus granulosa cells by 0.1% 
hyaluronidase and gentle aspiration through a mouth pipette. The oocytes were considered at 
metaphase II (MII) if a polar body was present in the perivitelline space.  
 
2.4 Quantitative Measurement 
Quantitative measurements were performed both manually and by using MATLAB® (code 
available upon request) and ImageJ (Rasband, W.S., ImageJ, National Institutes of Health, 
Bethesda, MD, USA, http://imagej.nih.gov/ij/, 1997-2014). Areas of fibrin degradation were first 
measured manually using ImageJ by drawing two orthogonal lines across the degraded area. We 
then calculated the area (A) of fibrin degradation using the diameter results (𝐴𝐴 = 𝜋𝜋(𝑑𝑑
2
)2). In the 
meantime, images were converted to binary by our custom MATLAB® program (Fig. 3). To 
achieve this, a threshold value was first determined by the program automatically analyzing the 
images with evenly exposed background. Then, areas with values higher than the defined 
threshold were converted to black whereas areas with lower than threshold values were 
converted to white in the binary images. Before submitting images for program to analyze fibrin 
degradation area, the sizes of follicles were calculated to compensate the area loss in the fibrin 
degradation circle due to follicle expansion using ImageJ. Then, area of degraded fibrin was 
measured by using the “Analyze” menu. Fibrin degradation area from both methods (M for 
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manual calculation and A for program measured areas) were recorded and compared as a factor 
indicating follicle health.  
To decrease variance, we took the following approaches: a) when capturing the images, we 
ensured a homogenous lighting in the background; b) we imaged beads that were floating in the 
center of the well and not close to the wall; c) we built a standard value of fibrin degradation area 
in control conditions, especially when switching to a different batch of aprotinin; d) adjusted 
features such as “threshold” and “fuzz factors” in the program; e) opted for manual definition of 
the boundary of fibrin degradation when necessary.  
 
2.5 Exposure of secondary follicles to doxorubicin 
For all doxorubicin treatments in this study, a stock solution of DXR was dissolved in 
dimethylsulfoxide (DMSO) and then diluted in growth media to achieve various DXR final 
concentrations. Doxorubicin actual concentrations in growth media were confirmed by 
measuring the auto-fluorescence of DXR using a fluorescence plate reader at room temperature 
(Fluoroskan Ascent, Labsystems, Finland, excitation 490 nm, emission 590nm). Since the plate 
reader cannot detect any fluorescence besides background readings for concentrations lower than 
10 nM, the lower DXR concentrations used in this study (1 nM, 0.1 nM, 0.01 nM and 0.005 nM) 
were determined based on sequential dilution of the 10 nM solution.  
For secondary follicles (120-130 µm in this study), 0.05% DMSO in GM was used as vehicle 
control. This lower concentration than what has previously been used for antral follicle culture 
(0.075%) (Peretz and Flaws 2013; Ziv-Gal et al. 2013) together with aprotinin showed no 
significant effects on in vitro folliculogenesis (data not shown).  
 
2.6 Statistical analysis  
Statistical analyses were performed using statistical software R (Lucent Technologies, USA). 
Two-sided t-test was performed to determine differences in follicle diameters between control 
and aprotinin treatment group at any given time point and fibrin degradation area data between 
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the two groups. Two-sided one-way ANOVA followed by t-tests was employed to test 
differences in follicle diameters for control and all doxorubicin treatment groups and following 
fibrin degradation. One-sided t-test was adapted by the MATLAB® to output follicle health 
evaluation based on fibrin degradation calculation. Values of p < 0.05 were considered 
statistically significant. 
 
3. Results and Discussion 
3.1 Optimal aprotinin concentration preserved intact fibrin degradation circle without 
affecting follicle health. 
During follicle culture, the fibrin component in the IPN is gradually degraded and diffuses from 
the hydrogel via proteolysis, with the initial clearance occurring adjacent to the follicle then 
progressing outwards to the edge of the hydrogel bead (Shikanov et al. 2009). The fibrin removal 
mirrors the follicle growth and volumetric expansion whereas the much slower degrading 
alginate remains as a structural and mechanical support. Thus, it is important to have both fibrin 
and alginate in the IPN to support folliculogenesis in vitro and for the fibrin component to serve 
as an optical density indicator of the follicle growth. Healthy growing follicles demonstrate 
strong proteolytic activity, which results in fast and poorly controlled fibrin degradation. 
Addition of aprotinin, a small molecule that inhibits plasmin proteolytic degradation, resulted in 
a slower fibrin degradation and more controllable optical density change. Our goal was to 
optimize aprotinin concentration to delay the fibrin degradation up to 8 days after encapsulation 
(D8). We identified the ideal range of the aprotinin concentration by varying concentrations in 
the follicle culture media during the first 4 days of the culture. Suboptimal concentrations of 
aprotinin (0.001 TIU/mL) resulted in uncontrolled fast fibrin degradation, while an overdose of 
aprotinin (0.01 TIU/mL) lead to follicle death due to matrix stiffness (Shikanov et al. 2011b). 
 
Our results showed that appropriate aprotinin concentration (0.025-0.05 TIU/mL) could sustain 
the required rate of degradation till D8, when antrum usually forms in growing follicles (Fig. 2a). 
We also measured follicle diameters to compare follicle growth in both conditions (Fig. 2b). To 
13 
 
confirm follicle health, we compared oocytes harvested from both conditions by in vitro 
maturation (IVM) (Fig. 2c). We confirmed that follicle health and oocyte maturation rate was not 
affected by this treatment as we did not see significant differences in survival rate (73.1% VS 
70.2%, Table 1) or metaphase II (MII) rate (78.2% VS 81.0%, Table 1) between the two 
conditions. 
 
Table 1. Summaries of follicle growth under different conditions. 





GM 73.1 87.0 177.46±5.33 322.46±11.50 78.2 
GM+Apr 70.2 86.4 223.91±11.70 288.45±23.10 81.0 
DXR treatments 
200 nM 0 0 150.20±5.04 143.63±6.96 0 
10 nM 0 0 128.91±2.49 129.13±3.36 0 
1 nM 0 0 102.59±1.97 100.59±2.33 0 
0.1 nM 0 0 106.70±4.05 100.80±3.83 0 
0.01 nM 35.4 28.6 175.12±3.01 179.51±7.18 0 
0.005 nM 47.6 64.3 178.06±9.48 217.61±14.03* 0 
%survive = (the number of survived follicles) ÷ (total number of follicles culture); %antrum = 
(the number of follicles with antrum) ÷ (the number of survived follicles); %MII = (the number 
of MII oocytes) ÷ (total number of oocytes matured). Follicle diameter data was presented as 
mean ± SEM. *: p<0.05. 
 
3.2 In vitro fibrin degradation positively correlated with in vitro folliculogenesis, serving as 
the foundation of the proposed system 
We established a correlation between fibrin degradation and follicle health, demonstrating that 
healthy follicles can actively degrade fibrin in the FA-IPN during culture, while the unhealthy 
ones cannot. Examples of original and MATLAB® processed images are shown in Fig. 3a. The 
left column showed images of a live and a dead follicle after 6 days of culture in FA-IPN. We 
specifically chose D6 images for this quantification because of the correlation between antrum 
formation and follicle atresia (Clarke et al. 2006; Matti et al. 2010). The right column showed 
MATLAB® processed binary images in which the fibrin degradation circles were intensified by 
this conversion. We used both manual and automated MATLAB®/ImageJ (Schneider et al. 
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2012) to measure changes in optical clarity due to fibrin removal and the results from both 
manual calculation and program measurements were recorded and compared in Fig. 3b. We did 
not see any significant difference between the two methods, confirming that the program is 
suitable to measure fibrin degradation in attempt to evaluate follicle health. However, a slightly 
greater variation was observed in program measurements, which could be due to the more 
forgiving aspect of manual calculation.  
 
The proposed measuring process for the high-throughput approach is demonstrated in the flow 
chart of the image analysis in Fig. 4. Stacks of original images of FA-IPNs are first converted to 
binary images, in which original optical clarity due to fibrin removal would appear as white 
whereas follicles and areas with fibrin presence would appear as black. Since the “black” 
follicles reside in the white area of fibrin degradation, we then correct for area loss due to follicle 
expansion for further MATLAB® program analyses. The program output is then based on the 
comparison of fibrin degradation area to control images. Since the system was designed to test 
for positive toxic effects on follicle health, therefore if the fibrin degradation area is significantly 
smaller (< mean – 1.5×SD), the output will be “X”, indicating positive toxic effects, i.e., dead 
follicles; if equal, output “?”, indicating further analysis may be necessary; and lastly if the 
degradation area is same as the control if the output is “√”, indicating absence of toxic effects, 
i.e., healthy follicles.  
 
3.3 Doxorubicin treatments confirmed system functionality and identified the IC50 for 
secondary follicles.  
To test our system, we treated cultured follicles with doxorubicin (DXR), a chemotherapeutic 
agent used to treat multiple cancers, including breast and ovarian cancer. DXR is an 
anthracycline that works by intercalating DNA, thus preventing replication and transcription.  
Depending on cell type and drug dose, DXR can cause topoisomerase II-dependent double-
strand DNA breaks or induce oxidative stress (Rebbaa et al. 2003). Recent evidence suggests that 
doxorubicin is moderately ovotoxic via direct apoptotic effects on follicles/oocytes and/or an 
impact on the entire ovary, which may potentially leads to infertility and premature ovarian 
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failure (POF) (Ataya and Moghissi 1989; Ben-Aharon et al. 2010; Jurisicova et al. 2006; Kim et 
al. 2006; Lee et al. 2006; Morgan et al. 2013; Perez et al. 1997; Rebbaa et al. 2003).  
 
We exposed cultured follicles to multiple concentrations of doxorubicin, ranging from 0 to 
200nM (Fig. 5). This range was determined based on what have been previously established as 
therapeutic plasma levels in patients undergoing DXR chemotherapy (Barpe et al. 2010; Rebbaa 
et al. 2001; Rebbaa et al. 2003; Wilkinson and Mawer 1974). None of the follicles survived in 
conditions with doxorubicin concentrations greater than 0.01nM (Table 1). We observed partial 
follicle survival of 35.4% (n=80) in 0.01nM treatment and 47.6% (n=92) in 0.005nM, compared 
to controls (73.1% and 70.2%, Table 1), which is in agreement with other reports (Ben-Aharon et 
al. 2010; Lee et al. 2006; Perez et al. 1997), Interestingly, follicles that survived 0.01 and 0.005 
nM doxorubicin exposures could not complete the maturation process. Some of the follicles did 
not contain oocytes, especially in 0.01 nM group (data not shown), and all oocytes were 
meiotically arrested compared to progression to meiosis II in controls (Table 1). 
 
Importantly, the diameter of survived follicles after 12 days of culture was significantly smaller 
than control conditions, which contributed to the meiotic arrest of the follicles. This delay in 
meiosis progression could be due to the mechanism of doxorubicin. DXR acts by intercalating 
DNA, and therefore prevents replication and transcription. As granulosa cells actively proliferate 
during folliculogenesis, DXR would interfere with this process, leading to impaired granulosa 
cell functions. The impacted granulosa cellular functions in turn, lead to impediment in the 
crosstalk to oocytes and therefore their arrest in meiosis. Details of underlying mechanism for 
this phenomenon are still under investigation in our lab. We are also interested in factors that 
may rescue the arrest oocytes, thus re-activate meiosis progression. 
 
Similarly, we performed both manual calculation and MATLAB® program measurement to 
quantify fibrin degradation with different DXR concentrations (Fig. 6).  In consistency with the 
smaller follicle sizes on D12 of culture, our results also showed significantly smaller area of 
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degraded fibrin on D6 for live follicles in the 0.005 nM DXR treatment group. For DXR 
concentrations higher than 0.01 nM, there was no detectable fibrin degradation by the program in 
most of the images, even though some images showed little if any degradation by eye.  
 
4. Conclusion 
The described approach uses a novel tool to screen multiple ovotoxicants and perform 
mechanistic studies in a physiologically relevant environment. Our results expand the 
armamentarium of in vitro screening assays for reproductive toxicology. We designed a 3D HTP 
in vitro ovarian follicle culture system using FA-IPN, which was successfully tested to evaluate 
the ovotoxic effects of Doxorubicin. The control of the fibrin degradation rate allowed toxicity 
screening for extended periods of culture, without disruption of follicle development.  The 
customized automated MATLAB® image processing software supported the hands-off approach 
to screen multiple conditions in a high throughput manner. To summarize, we established a 3D 
in vitro ovarian follicle culture HTP system that could be used to screen toxicants for female 
reproductive system.  
 
5. Disclosures 
The authors declare that there are no conflicts of interest. This work has been published in PLoS 
One in 2015. 
 
6. Funding 





The authors would like to acknowledge Ingredients Solution, Inc. and Baxter International Inc., 
who kindly provided the alginate and fibrinogen-thrombin kits (through a Material Transfer 
Agreement to AS) respectively for the use in the FA-IPNs. The authors would also like to thank 




III. Detection of lindane and 7,12-dimethylbenz[a]anthrance toxicity at low concentrations 
in a three-dimensional ovarian follicle culture system 
In conjunction with: Cara J. Young, Rita Loch-Caruso, Ariella Shikanov 
 
1. Introduction 
Contamination of the environment with organic pollutants has emerged as a significant public 
health concern due to the pervasive nature of these xenobiotics. Such contaminants could target 
the ovaries, thus exerting long-lasting adverse effects on women’s reproductive health. Females 
are born with finite numbers of follicles, which sustain the ovarian endocrine function and 
fertility (Hirshfield 1991). Ovotoxic xenobiotic exposure can deplete the non-renewable 
follicular reserve, resulting in premature ovarian insufficiency (POI) (Bhattacharya and Keating 
2012; Hoyer and Keating 2014; Martin et al. 2009). Noticeably, follicles at all stages of 
development can be impacted by xenobiotic exposure, leading to deleterious effects on follicle 
development, oocyte competence, ovulation and hormone production (Mattison 1993).  
 
A large number of chemicals affect ovarian functions. Lindane (gamma-
hexachlorocyclohexane), a persistent organic pollutant used as a pesticide/insecticide, causes 
impairments of female fertility by altering ovarian follicle development and function in women, 
laboratory and farm animals (Tiemann 2008). Lindane inhibits intercellular communication 
through gap junctions (Loch-Caruso et al. 2004; Loch-Caruso et al. 2005), and suppresses 
follicle-stimulating hormone (FSH) and transforming growth factor beta 1 (TGF β1)-stimulated 
steroidogenesis in rats (Ke et al. 2005). Additionally, lindane can also abolish oocyte-directed 
follicle organizing activity in vitro (Li and Mather 1997). The use of lindane was banned in 
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agriculture by the Stockholm Convention on Persistent Organic Pollutants (Vanden Bilcke 
2002). However, it continues to be available as a pharmacological treatment of scabies and lice. 
Because of its widespread use, lipophilic nature, and resistance to biodegradation, low 
concentrations of lindane can persist in lipid-rich human tissues (Kutz et al. 1991). However, 
lindane toxicity to ovarian follicles at low concentrations is yet to be established, especially in a 
3D culture environment.  
 
7,12-dimethylbenz[a]anthracene (DMBA) is an immunosuppressor and a powerful organ-
specific laboratory carcinogen (Miyata et al. 2001). As a polycyclic aromatic hydrocarbon 
(PAH), DMBA is found in car exhaust fume and cigarette smoke (Gelboin 1980). It is evidenced 
that female smokers experience ovarian senescence at an earlier age compared to their non-
smoking counterparts (Jick et al. 1977). It has been shown that DMBA exposure induces DNA 
double strand breaks and subsequent DNA repair response in cultured neonatal rat ovaries 
(Ganesan et al. 2013). DMBA depletes ovarian follicles at all developmental stages as suggested 
by in vitro neonatal ovary cultures (Bhattacharya and Keating 2012; Ganesan et al. 2013; 
Ganesan et al. 2015; Igawa et al. 2009; Nteeba et al. 2014). DMBA toxicity to single follicles, 
however, has not been established in vitro. Such knowledge can provide insights to low 
concentration effects of environment pollutants and compensate current regulations.  
 
Follicles are the functional units of ovaries, and because of their non-renewable nature are most 
sensitive to chemical or physical damage (Lebbe et al. 2017). During follicular development, 
primordial follicles undergo a series of critical changes in character, both histologically and 
hormonally. Primordial follicles activate and develop into primary follicles and later secondary. 
A secondary follicle is a growing follicle consisting of an oocyte and two or more layers of 
supporting granulosa cells. It has been well established that secondary follicles can be cultured 
and matured individually and independent of ovarian tissue or feeder cells (Xu et al. 2006). 
Encapsulated in vitro follicle growth (eIVFG) systems, such as fibrin-alginate interpenetrating 
networks (FA-IPNs), recapitulate key events of mammalian follicle development in 
physiological, in-vivo-like conditions and serve as a tool to screen for toxic effects of 
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compounds (Zhou et al. 2015). In the FA-IPN eIVFG system, follicles are individually cultured 
in a 96-well plate, which allows study of low-concentration effects of toxicants with high 
sensitivity in each individual follicle and oocyte. Therefore, the proposed system serves as a 
robust proxy to study toxicity of xenobiotics on the growing pool of follicles (Braw-Tal 2002; 
Xiao et al. 2017a; Xu et al. 2015). 
 
Noticeably, people are exposed to a cocktail of xenobiotics and yet, limited scientific 
information is available on potential toxic effects of mixtures of environmental pollutants on 
human reproductive health. Therefore, here we investigated ovarian follicle survival, growth, and 
maturation after exposure to lindane and DMBA individually and as lindane-DMBA mixtures.  
 
In this study, we exposed mouse secondary ovarian follicles to lindane and DMBA on days 0, 2, 
and 4 of eIVFG. First, we identified the lethal concentrations of lindane and DMBA that kill 
10% and 50% of the population of cultured follicles (LC10s and LC50s). Then, we exposed 
follicles to various combinations of mixtures of lindane and DMBA at concentrations with 
matching potency to evaluate the combinational effects of the two toxicants. Our results showed 
concentration-dependent adverse effects on follicles upon exposure to lindane and DMBA, either 
individually or in a mixture, at much lower concentrations than traditional toxicological methods.  
 
2. Methods 
All chemicals were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise specified. 
Media formulations were purchased from Thermo Fisher Scientific (Carlsbad, CA). Nalgin MV-
120 sodium alginate (Carrageenan, Xanthan, Alginate, Ingredients Solution, Inc., Waldo, ME, 
USA) and the fibrinogen-thrombin kits (Baxter Healthcare, BioScience Division, Westlake 





Mice were purchased (Harlan, Indianapolis, IN), and housed in ventilated cages in a temperature 
and light controlled environment (12L:12D), and provided with food and water. Animals were 
treated in accordance with the guidelines and regulations set forth by the National Institutes of 
Health Guide for the Care and Use of Laboratory Animals and the established Institutional 
Animal Use and Care (IACUC) protocol at the University of Michigan. Experiments with 
animals were performed in strict accordance with the protocols approved by the University of 
Michigan IACUC. All animals used in this study were euthanized by overdose of isoflurane via 
inhalation followed by decapitation. 
 
2.2 Ovarian follicle isolation, encapsulation and culture 
Secondary follicles (120 – 135 µm) were mechanically isolated from 12 – 14 day-old F1 hybrids 
(C57BL/6NHsd inbred × CBA/JCrHsd) as previously described (Shikanov et al. 2009; Zhou et 
al. 2015). Only follicles with intact morphology were selected for encapsulation and culture. 
Selected follicles were encapsulated individually in FA-IPN as previously described (Zhou et al. 
2015). Encapsulated follicles were placed in 96-well plates, with each well containing 100 µL 
growth medium (50% αMEM Glutamax and 50% F-12 Glutamax supplemented with 1 mg/mL 
bovine fetuin, 3 mg/mL bovine serum albumin [BSA], 0.1% insulin-transferrin-selenium [ITS], 
and 10 mIU/mL urofollictropin (Bravelle® 75 IU urofollitropin for injection, Ferring 
Pharmaceuticals, Saint-Prex, Switzerland). For all experiments, follicles were cultured at 37 ˚C 
with 5% CO2. Follicles were imaged every 2 days using an inverted Leica DMI 3000 microscope 
with 20X objectives (Leica Microsystems, Bufflo Grove, IL). After imaging, half of the growth 
medium (50 µL) was replaced with pre-equilibrated, fresh medium.  
 
Follicles were considered dead if they showed dark granulosa cell layers, and/or if the oocyte 
was visibly fragmented. Survival curves were created using Graphpad Prism 7 software by 
recording the numbers of dead follicles on specific days of cultures. Dead follicles were 
excluded retrospectively in growth curves. Diameters of live follicle were obtained by averaging 
2 perpendicular measurements form basement membrane to basement membrane of individual 
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follicles in ImageJ software (National Institute of Health, Bethesda, MD). Growth curves of 
survived follicles were then obtained by plotting the average follicle diameters over time.  
 
2.3 In vitro exposure of toxicants to follicles 
Cultured follicles were exposed in vitro to either lindane or DMBA or both toxicants on Days 0, 
2, and 4 of eIVFG. Lindane and DMBA were first dissolved in dimethyl sulfoxide (DMSO) and 
then diluted with growth media to reach desired concentrations. The final concentrations of 
DMSO were kept at 0.05% for all toxicant treatment conditions, which was consistent with 
previous publications (Zhou et al. 2015; Ziv-Gal et al. 2013). If treated, toxicants of the same 
concentration were also added to the fresh media on Days 2 and 4 to keep the toxicant 
concentration constant. Starting on Day 6, fresh media without toxicant was used when changing 
media.  
 
2.4 In vitro follicle maturation (IVFM) 
In vitro follicle maturation was performed on day 12 of eIVFG as previously described (Zhou et 
al. 2015). Oocytes were denuded from surrounding cumulus cells using 0.3% hyaluronidase. 
Oocytes were considered as metaphase II (MII), if a polar body was present in the perivitelline 
space. If the nucleus was clearly visible, oocytes were considered arrested at prophase I in the 
germinal vesicle stage (GV). If the nucleus was not visible, oocytes were considered to have 
undergone germinal vesicle breakdown (GVBD). Fragmented and/or shrunken oocytes were 
considered as degenerated (DG).  
 
2.5 Statistical analysis 
All statistical analyses were performed in GraphPad Prism 7 software. Follicle survival and 
growth were analyzed from 3 to 5 independent cultures in which 15 – 30 follicles were included 
for each experimental group. Follicle growth in different treatment groups was analyzed using 
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two-way ANOVA. Post hoc Dunnett’s multiple comparisons test was performed to determine 
treatment effects compared to control. The significance level was set at p < 0.05.  
 
3. Results 
3.1 Concentration-dependent response to lindane 
Our results demonstrate the concentration-dependent toxicity of lindane on cultured secondary 
ovarian follicles. In the control group, the FA-IPN encapsulation maintained the 3D architecture 
of follicles and supported follicle growth from secondary to antral stage (Fig. 7A), with follicle 
diameters increased from 133.2 ± 2.7 µm on day 0 to 323.4 ± 11.8 µm (Fig. 7C) on day 12. 
Follicle survival and growth were comparable between untreated controls and 0.25 µM lindane 
(Fig. 7), but significantly decreased when follicles were treated with higher concentrations of 
lindane. When treated with 0.5 µM lindane, follicle survival significantly decreased from 95.5% 
on day 2 to 37.3% on day 12 of culture (Fig. 7B), and the diameters of surviving follicles were 
significantly smaller (Fig. 7C).  Moreover, oocytes in the surviving follicles exposed to 0.5 µM 
lindane that reached the diameter of 265.8 ± 13.1 µm on day 12 of eIVFG (Fig. 1C) presented 
with an elongated, oval-shape (Fig. 7A). When treated with 5 µM lindane, more than 80% of the 
follicles died within the first 8 days of culture (Fig. 7B), often showing extruded and/or 
degenerated oocytes (Fig. 7A): only 3.7% of follicles survived after 12 days of eIVFG. 
Normalizing to control, we determined that 0.5 µM lindane is the LC50 for in vitro cultured 
single secondary follicles and 0.25 µM lindane as the LC10.   
 
3.2 Concentration-dependent response to DMBA 
Similar to lindane, DMBA showed a concentration-dependent pattern of toxicity to cultured 
ovarian follicles (Fig. 8A). The survival and growth of follicles exposed to 6.25 nM DMBA 
slightly decreased compared to untreated controls, with 61.2% of follicles still alive on day 12 of 
eIVFG, compared to 71.3% in controls (Fig. 8B and 8C). When treated with 12.5 nM DMBA, 
follicle survival significantly decreased to 32.4% on day 12 of culture (p < 0.0001, Fig. 8B and 
8C). After 4 days of exposure, follicles treated with 12.5 nM of DMBA grew from 168.7 ± 14.5 
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µm on day 6 to 201.2 ± 15.8 µm on day 12 (Fig. 8C), compared to 323.4 ± 11.8 µm on day 12 in 
controls. Additionally, when treated with 25 nM of DMBA, only 17.6% of follicles survived 
after 6 days of culture. Normalizing survival data to controls, we determined the LC10 and LC50 
of DMBA for secondary follicles to be 6.25 nM and 12.5 nM, respectively. The significantly 
lower LC50 of DMBA indicated that DMBA is a more potent toxicant than lindane.  
 
3.3 Concentration-dependent response to mixtures of lindane and DMBA 
To examine the combinational effects, we exposed in vitro secondary ovarian follicles to 
mixtures of lindane and DMBA based on their potencies as individual toxicants. Two mixtures 
were tested to investigate the interactions between the two toxicants: one mixture was at the 
toxicant LC10s (0.25 µM lindane + 6.25 nM DMBA) and the second mixture at the LC50s (0.5 
µM lindane + 12.5 nM DMBA).  
 
Similar to individual toxicant exposures, we observed concentration-dependent responses of 
cultured follicles when exposed to the LC10 and LC50 mixtures of lindane and DMBA (Fig. 
9A). When compared to untreated controls, follicle survival rate on day 12 in the LC10 mixture 
was only slightly lower than the controls, compared to a more significant decrease in the LC50 
mixture (Fig. 9B). Interestingly, the growth of the follicles exposed to the mixtures of DMBA 
and lindane exhibited a pattern that resembled follicles exposed to lindane alone and not DMBA. 
The mean diameter of the follicles exposed to the mixture on day 12 (296.4 ± 13.0 µm in LC10 
mixture, 258.5 ± 19.2 µm in LC50 mixture) closely matched diameters of follicles exposed to 
lindane alone (295.9 ± 10.9 µm in 0.25 µM, 265.8 ± 13.1 µm in 0.5 µM), and were slightly 
larger than those exposed to DMBA alone (285.4 ± 21.3 µm in 6.25 nM, 201.2 ± 15.8 µm in 12.5 
nM) (Fig. 9C). This finding suggests a dominant role of lindane in the toxicity on follicle growth 
in the mixtures.  
 
3.4 Effects of lindane and DMBA on oocyte quality 
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In vivo, immature oocytes must undergo a process of maturation from prophase I to metaphase II 
as follicles mature. Similarly, oocytes cultured in vitro must mature and progress to metaphase II 
in response to exogenous gonadotropins upon in vitro maturation. By examining the stages of the 
oocytes harvested from surviving follicles after toxicant exposure, we investigated how low 
concentrations of toxicant affected oocytes quality in surviving follicles.  
 
Exposure to lindane and DMBA singularly and as mixtures demonstrated concentration-
dependent effects on oocyte quality, resulting in greater rates of immature and degenerated 
oocytes and lower rates of oocytes that resumed meiosis, as indicated by oocytes arrested in GV 
stage (Fig. 10). When treated with 0.25 µM of lindane, only a slight increase (10%) was 
observed in oocytes arrested in GV stage compared to untreated controls, and a slight decrease 
(10%) in degenerated oocytes after IVFM. Exposure of the follicles to 0.5 µM lindane caused a 
significant (2.6-fold) increase in GV and a less pronounced 10% decrease in DG (Fig. 10). These 
results further demonstrate how oocyte quality decreases as a function of increasing toxicant 
concentration. A similar decrease in oocyte quality was observed in DMBA-treated follicles. The 
majority of oocytes from 6.25 nM DMBA treatment were arrested in GV, which was a 3-fold 
increase, compared to the controls (Fig. 10). Noticeably, the 12.5 nM DMBA treatment resulted 
in mostly degenerated oocytes, which was a 4.3-fold increase compared to controls (Fig. 10). 
Clearly, exposure to toxicants in early days (days 0, 2, and 4) of eIVFG shifted oocyte quality 
towards meiosis-incompetent stages after 12 days in culture. The shift was more apparent in 
DMBA treatments than in lindane, further implying the higher toxicity of DMBA than that of 
lindane.  
 
Interestingly, follicle exposure to mixtures of lindane and DMBA on days 0, 2, and 4 of eIVFG, 
resulted in attenuated effects on the oocytes, compared to exposure to single toxicants (Fig. 10). 
An increase in immature oocytes was only 0.1-fold in the LC10 mixture, and 0.4-fold in the 
LC50 mixture, compared to controls (Fig. 10). The observed attenuated effect of the mixture on 
oocytes is consistent with the less affected follicle survival and growth in the mixture conditions 





Organic xenobiotics, such as lindane and DMBA, act at extremely low serum concentrations 
because of their lipophilic and pervasive nature. This study investigated for the first time the 
direct toxic effects of lindane and DMBA on individual in vitro cultured mouse secondary 
follicles. We used a 3D hydrogel-based in vitro culture system that allows for toxicant 
assessment in follicles cultured in in-vivo-like, physiological conditions. Our results 
demonstrated that lindane and DMBA adversely affect individually cultured mouse secondary 
ovarian follicles at micromolar and/or nanomolar levels. The concentrations of lindane and 
DMBA used in this study are in the same range as concentrations of other xenobiotics, such as 
doxorubicin, that have been previously established for individually cultured mouse secondary 
ovarian follicles by our and other groups (Xiao et al. 2017b; Zhou et al. 2015).  
 
The data about outcomes of human exposure to environmental toxicants are limited. Current 
toxicity research on human degenerative diseases relies strongly on animal models, mainly 
rodents. Whole-animal studies allow for the examination of complex phenotypes that often 
involve multiple mechanisms, and they may better represent human exposure situations. Lindane 
has been shown to be toxic to the reproductive systems in both males and females in various 
species (Basavarajappa et al. 2016; Cyr et al. 2016; Sharma et al. 2017; Yuksel et al. 2016), even 
at low doses (0.25 mg/kg/day, 1/1000th of the LD50 of lindane) (Sharma et al. 2017). Similarly, 
DMBA, a common PAH, is also known to have adverse effects on fertility and ovarian functions, 
such as litter loss ((Basavarajappa et al. 2016) and ovarian follicle depletion (Shiverick 2017). 
While they offer certain advantages over cell-based testing assays, animal models can be labor 
intensive, time consuming and costly, and therefore are used to test relatively small numbers of 
chemicals (Collins et al. 2008). In contrast, in vitro assays allow greater flexibility and can 
rapidly provide information on large numbers of chemicals at low cost. Compared to animal 
studies, in vitro assays allow grouping chemicals according to their effects on key biological 
pathways and/or testing chemicals over a broad range of concentrations to capture varied 
exposure scenarios in a rapid and relatively inexpensive manner (M. E. Andersen and D. 
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Krewski 2009). Consistent with animal studies, various in vitro assays confirmed the toxicity of 
lindane and DMBA to the female reproductive system (Bhattacharya and Keating 2012; Ganesan 
et al. 2013; Igawa et al. 2009; Li and Mather 1997), using organ culture and ovarian follicle and 
oocyte cultures. Yet, a significant challenge remains as to how to maintain the physiological 3D 
structure of a multicellular and multicomponent nature of ovarian follicles and tissues of the 
reproductive tract.  
 
The 3D hydrogel-based culture system addresses the challenges of maintaining the multilayered 
structure of ovarian follicles and allows focusing on a specific follicle population. With the 3D 
support from the hydrogel, the follicles develop in a more physiological environment, 
maintaining a fluid-filled antrum and expanding to their in vivo preovulatory sizes. The enclosed 
antrum, together with the antral fluid, mimic the diffusion patterns in vivo, and could serve as a 
buffer or as a reservoir in follicles exposure to toxicants. Because of the unique properties of the 
enclosed antrum and presence of the antral fluid, the low concentrations used in our study could 
better elucidate the mechanisms of the toxicity of lindane and DMBA to developing follicles in 
an in-vivo-like environment. Our results demonstrated the toxicity of lindane and DMBA to the 
growing pool of ovarian follicles at low concentrations and their adverse effects on oocytes from 
surviving follicles. These findings complemented what has already been established for the 
moderate and high concentrations. Considering the complexity of potentially non-monotonic 
dose-response curves, studying the toxic effects at micro doses are of considerable importance 
for scientific and regulatory communities (Vandenberg et al. 2012). Importantly, recent 
epidemiological data suggested links between environmentally relevant low concentrations and 
disease prevalence via industrial accidents or occupational applications (Vandenberg et al. 2012).  
 
Lindane and DMBA affect follicle development via different mechanisms. Lindane alters 
folliculogenesis by inhibiting gap junction formation between the granulosa cells (Li and Mather 
1997; Tiemann 2008) and suppresses FSH and TGF-β1-stimulated progesterone production (Ke 
et al. 2005; Nejaty et al. 2001). The effects of lindane on gap junctions can be detected at 24 
hours post incubation with 40 µM of lindane (Ke et al. 2005). Upon bioactivation, lindane 
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undergoes further complex metabolism via CYP450s, which leads to lindane conjugation and 
deactivation (Fig. 11B). However, in the case of DMBA, in addition to toxicity caused by the 
parent toxicant, metabolites formed via bioactivation also have detrimental effects on ovaries. 
DMBA requires bioactivation via cytochrome p450 (CYP 450) isoforms 1A1 (CYP 1A1) and 
1B1 (CYP 1B1) and microsomal epoxide hydrolase (mEH) (Igawa et al. 2009; Shimada et al. 
2003). It has been previously shown that the ovaries are capable of bioactivating DMBA via 
CYP 450s that are present in granulosa cells (Ganesan et al. 2015; Nteeba et al. 2014). The 
metabolite, DMBA-3, 4-diol, was shown to have a greater toxicity to cultured neonatal mice and 
rat ovaries than the parent agent (Igawa et al. 2009). Consequently, we observed that DMBA is 
more toxic than lindane to in vitro cultured ovarian follicles, given that LC10 of lindane is 40 
times greater than that of DMBA.  
 
We hypothesized that lindane and DMBA will produce a synergistic or additive effect, resulting 
in augmented toxic effects when combined. Interestingly, we did not observe such interactions 
between the two toxicants in our culture system. Instead, our results suggest that follicles 
exposed to the mixture of lindane and DMBA resembled the response of the follicles exposed to 
lindane alone. The oocyte quality from mixture treatments was inferior to the oocyte quality in 
control follicles. However, when compared to the oocytes exposed to individual toxicants, the 
decrease in oocyte quality was ameliorated, suggesting potential competitive interactions 
between lindane and DMBA. This phenomenon could be explained by the competition of the 
CYP450s in granulosa cells upon exposure to the mixtures. Given the 40-fold difference between 
lindane and DMBA concentrations, the abundance of lindane molecules would have a greater 
chance of interacting with the limited number of CYP450s present in the granulosa cells of a 
single follicle. As lindane molecules outcompete DMBA molecules, follicle survival and growth 
shifted towards lindane only exposure. Additionally, the detoxification of lindane may help 
ameliorate the decrease in oocyte quality as seen in individual toxicant exposure. 
 
Taken together, our results in 3D in vitro system complemented the existing data regarding 
toxicity of lindane and DMBA to mouse ovarian follicles at higher concentrations. The in-vivo-
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like 3D matrix provides a biomimetic, physiological environment for the cultured follicles, 
similar to animal studies. Yet, the 3D culture assay is less time consuming, allowing for 
decoupling various components and significantly less expensive compared to animals. The data 
collected from these experiments could be used for in silico modeling for forecasting potential 




We applied a 3D in vitro ovarian follicle culture system to study the toxic effects of lindane and 
DMBA separately and as mixtures. As follicles were individually cultured in in-vivo-like 
environment, we were able to detect lindane and DMBA toxicity at ultra-low concentrations, 
complementing data established in moderate and/or high concentrations. Follicle survival and 
growth were affected by toxicant exposure in a concentration-dependent manner. Oocyte quality 
from the surviving follicles showed a shift towards meiotically incompetent stages compared to 
control, consistent with decreased follicle survival and inhibited follicle growth. Interestingly, 
when exposed to mixtures of lindane and DMBA at LC10s and LC50s, lindane was dictating the 
toxic effects, possibly due to the greater number of lindane molecules. Additionally, the 
inferiority of oocyte quality was ameliorated compared to individual toxicant exposure, 
indicating competitive interactions between lindane and DMBA. Taken together, the proposed 
system could serve as a new tool to study mixtures of environment toxicants in a physiological 







IV. A novel biomimetic matrix supports early stage follicle development  
for translational fertility preservation applications 




With improved survival rates among young patients with cancer, recent bench-to-bedside 
translation of new techniques to preserve fertility, and increased awareness of reduced fertility, 
options for family planning are now being offered to patients who have received a diagnosis of 
cancer (Jeruss and Woodruff 2009). It remains challenging for the biomedical community to 
develop safe fertility preservation methods for patients with cancer, especially the improvement 
of personalized, patient-specific approaches and the identification and reduction of the risks of 
cancer relapses (Woodruff 2007). Current methods of fertility preservation include hormone 
stimulation in women followed by either embryo or oocyte cryopreservation. As an established 
component of assisted reproductive technologies (ARTs), the success rate of oocyte 
cryopreservation has risen, and the increasing use of vitrification offers has improved outcome. 
Consequently, increasing numbers of women undergo oocyte cryopreservation for both medical 
and social reasons (Argyle et al. 2016; Noyes et al. 2009). Both techniques, however, require a 
delay in cancer treatment for up to 1 month, which may not be an option for some patients 
(Jeruss and Woodruff 2009). Additionally, neither can be used for pre-pubertal patients. New 
methods, such as autologous tissue transplantation, are also on the horizon (Agarwal and Chang 
2007; Donnez et al. 2004; Donnez et al. 2013; Erin R West et al. 2007). However, there are 




In vitro culture of ovarian follicles that results in fertilizable oocytes has great potential in 
providing fertility preservation options for both pre-pubertal and post-pubertal patients. Since 
patients do not need to go through hormone stimulation, there is no need or risks of delaying the 
cancer treatment. Additionally, immature follicles are cultured in vitro, thus greatly reducing the 
risks of reintroducing cancerous cells back to patients. A number of encapsulated in vitro follicle 
growth (eIVFG) systems for single follicles have been established for a number of species, 
including human (Shikanov et al. 2009; Shikanov et al. 2011a; Xiao et al. 2015; J Xu et al. 2011; 
Xu et al. 2013b; Xu et al. 2006; Xu et al. 2009a; Xu et al. 2009b; M Xu et al. 2011). However, 
most of the above eIVFG are designed for secondary follicles with at least two layers of 
granulosa cells (type 4), starting from ~130 µm in diameters.  However, smaller immature 
follicles less than 120 µm in diameter, including primordial, primary and early secondary 
follicles, are more abundant in the ovary and developing successful culture systems for these 
classes of follicles will maximize the potential of eIVFG systems. To obtain mature, fertilizable 
oocytes, new culture systems need to be established for smaller follicles as they need additional 
soluble and insoluble factors in the beginning of in vitro folliculogenesis, before acquiring 
autonomy after reaching 130 – 150 µm in diameters.  
 
Indeed, efforts have been put to developing eIVFG systems for primary and early secondary 
follicles.  Follicles in the early stages of development are gonadotropin-independent, responding 
mostly to the various local paracrine and autocrine factors from surrounding somatic cells, such 
as stromal cells, macrophages, and other neighboring follicles (Hornick et al. 2013; Laronda et 
al. 2014; Tagler et al. 2012). These additional cells/follicles have been shown to improve 
follicular growth and development, through production of essential factors, in addition to the 
removal of toxic wastes from the culture medium (Hajializadeh et al. 2008). However, the gap 
still remains between translating eIVFG systems established for smaller follicles to clinical 
application. On one hand, co-culturing multiple human follicles in a single environment could be 
of low efficiency and potentially wasteful. As humans are mono-ovulatory species, co-culturing 
multiple follicles together results in a potential dominant follicle selection, an obstacle that 
cannot be overcome with physiological levels of hormones. Co-culturing individual follicles with 
stromal cells that serve as feeder cells and provide the smaller follicles with the additional 
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support presents as a translational alternative. However, currently established co-culture eIVFG 
systems such as those with macrophages or theca–interstitial cells (TICS) (Tingen et al. 2011), 
lack translational sources of cells to provide for the smaller follicles. Therefore, it is a must to 
find a feeder cells source that can be used in clinical settings in a patient-specific way. 
 
Adipose derived stem cells (ADSCs) are a clinically translational option to support in vitro 
culture of ovarian follicles. Adipose tissue is an abundant, accessible, and replenishable source of 
adult stem cells that can be isolated in patient-specific ways from liposuction waste tissue by 
collagenase digestion and differential centrifugation (Gimble and Guilak 2003). These ADSCs 
are multipotent and have been used in various applications for regenerative medicine (Gimble et 
al. 2007). Factors secreted by ADSCs in vitro, including vascular endothelial growth factor 
(VEGF) and basic fibroblast growth factor (bFGF), can help with the initial survival of smaller 
follicles in vitro (Markstrom et al. 2002). With their translational potentials, ADSCs pose a novel 
alternative source for co-culture of ovarian follicles. 
 
In addition to tailoring the source of feeder cells to patients, another essential aspect of 
developing new eIVFG for clinical applications is the in vitro culture microenvironment, such as 
rigidity and degradability during the follicle culture period. Smaller follicles, such as primordial 
and primary, reside in the cortex, which is the more rigid part of the ovaries, compared to the 
softer medulla parts where growing follicles usually are (Shikanov et al. 2011a). This 
characteristic architectural design of the ovaries and follicles distribution in vivo also indicates 
the need for a dynamic and degradable in vitro microenvironment to accommodate the 
volumetric expansion, especially for larger species than mouse (Telfer and Zelinski 2013). As 
the initial survival of the smaller follicles may require the additional support from ADSCs, it is 
also necessary to consider the survival and proliferation of ADSCs.  
 
With its tunable physical properties, poly (ethylene glycol) (PEG) is a biocompatible synthetic 
polymer that can be modified to meet the requirements of both ovarian follicles and ADSCs. 
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PEG hydrogels crosslinked with proteolytic sequences, can be degraded in response to cell-
secreted proteases, thus creating space for follicular expansion without exerting excessive 
compressive force. It has been shown that PEG hydrogels enabled in vitro encapsulation and 
maturation of individual mouse secondary ovarian follicles (140 – 150 μm) (Shikanov et al. 
2011a). In this chapter, we investigated a novel beneficial co-encapsulation system for mouse 
primary and early secondary ovarian follicles (90 – 110 µm) co-encapsulated ADSCs derived 
from female mice. Specifically, we pioneered a PEG hydrogel that incorporates degradable 
crosslinkers that are both plasmin and matrix metalloproteases (MMP) sensitive to 
simultaneously meet the requirement of expanding follicles and proliferating cells.  
 
2. Materials and Methods 
2.1 Hydrogel materials and preparation 
8-arm PEG-Vinyl sulfone (PEG-VS, hexaglycerol, 40,000 g mol−1, >99% purity, Jenkem 
Technology) was used without further modification. Two different tri-functional crosslinking 
peptide were compared for the co-encapsulation of follicles and ADSCs: plasmin-sensitive Ac-
GCYK↓NSGCYK↓NSCG (YKNS) (1739.0 g/mol, >90%, GenScript, cleavage site indicated by 
↓, cysteines with reactive thiols in bold) and MMP-sensitive Ac-
GCRDVP↓MSMRGGDRCGYK↓NSCG-COOH (YKNS/VPMS) (2397.1 g/mol, >90%, 
CelTech). The hydrogels were formed via Michael-type addition (MTA) chemistry in 50 mM 
HEPES buffer at 37 ˚C under physiological pH (7.4). The stoichiometric ratio of -VS to thiol (-
SH) groups was kept at 1:1 ratio for all experiments. Gelation was allowed for 5 mins for YKNS 
gels and 10 mins for YKNS/VPMS gels before terminating by transferring gels to pre-
equilibrated media and/or phosphate buffered saline (PBS).  
 
To investigate the swelling properties and rigidity of hydrogels under similar conditions that 
maintain ovarian follicle and ADSCs viability, crosslinked gels were subsequently submerged in 
PBS prior to measuring either swelling ratio or storage moduli. The storage moduli (G’) were 
studied after overnight swelling in PBS using AR-G2 rheometer (TA Instruments, New Castle, 
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DE) equipped with 20mm parallel plates. To calculate swelling ratios, individual gels were 
weight after 24 hours of swelling in PBS. The mass swelling ratio (Qm) was calculated by 
dividing the mass of the swollen hydrogels (ms) by the theoretical mass of the dry gel 






2.2 Cell viability assay 
Encapsulated ADSCs were stained with a LIVE/DEAD (488/570) kit (ThermoFisher) on Day 7 
to evaluate cell viability with some modification to the manufacturer’s protocol. Upon aspirating 
the medium from the wells, the gels were quickly rinsed with 100 µL of PBS. Then, 100 µL of 
the LIVE/DEAD dye was subsequently added to each well. The gels were incubated with the dye 
for 15 minutes at room temperature before imaging.  
 
2.3 Follicle isolation and co-encapsulation with ADSCs 
Details of the isolation and encapsulation process can be found in the appendix to this 
dissertation. Briefly, primary and early secondary mouse ovarian follicles (≤120 µm) were 
mechanically isolated from prepubertal female mice (F1 hybrids of C57B6 × CBA/J) that were 
10 – 12 days of age. Healthy looking follicles were then individually encapsulated in 5% PEG-
VS crosslinked with either YKNS or YKNS/VPMS. The PEG-VS and crosslinking peptides 
were dissolved in the isotonic HEPES buffer (pH=7.4 at 37°C) then mixed at a 1:1 volumetric 
ratio. Gels were mixed at a reactive group stoichiometric ratio of 1:1 (VS:SH) to reduce the 
impact of disulfide bond formation in the peptide solution on the cross-linking efficiency during 
cell culture. The ADSCs were then resuspended in this mixture of precursors to 5 × 105 cells/mL. 
This cell suspension was subsequently cast between parafilm-coated glass slides before 
individual follicle addition to each 10 μL gel. The gels were allowed to cross-link at 37 ˚C for 5 
minutes for YKNS and for 10 minutes for YKNS/VPMS before terminating the chemical 




2.4 Follicle culture and maturation in vitro 
Individually encapsulated follicles with ADSCs were allowed to rest in MM for at least 30 
minutes before being transferred to wells of 96-well plates for culture. Same culturing schemes 
were followed as described in the appendix with slight modification. Individual gels containing 
follicles and ADSCs were cultured with 150 µL of growth media (GM). Every 2 days, half of the 
media (75 µL) was replaced with fresh, pre-equilibrated GM after imaging.  
 
To evaluate the translational potential of our culture for fertility preservation, the quality of the 
oocytes harvested from cultures was examined by in vitro follicle maturation (IVFM) as 
previously described (Zhou et al. 2015) with some modification. Instead of digesting the gel, 
after 12 days of culture, gels containing follicles reaching at least 300 µm were selected and 
transferred to a 35 mm dish with pre-equilibrated MM. Working under a dissection scope, the 
mature follicles and/or the cumulus oocyte complexes (COCs) were carefully dissected out of the 
gels using 26G ½ needles. Mature follicles and COCs were subsequently transferred to pre-
equilibrated maturation media (MatM) and incubated for 20 hours. After cumulus expansion, 
0.1% hyaluronidase was added with a gentle aspiration with a pipette to separate oocytes and the 
cumulus granulosa cells. The oocytes were considered at metaphase II (MII) if a polar body was 
present in the perivitelline space. If the germinal vesicle was still visible, the oocyte was 
classified as GV. If appeared segmented, the oocyte was considered degenerated (DG).  
 
2.5 Statistical analyses 
All statistical analyses were performed using ANOVA with a Bonferroni post-test. P < 0.05 was 





3.1 Hydrogel properties under physiological conditions 
We modified the previously established PEG-VS based hydrogel for the co-encapsulation of 
early stage mouse ovarian follicles and ADSCs. PEG-VS based hydrogels were used because of 
its solely proteolytic degradation. To make the hydrogel degradable by both follicles and 
ADSCs, we combined the reported plasmin-sensitive YKNS sequence with a MMP-sensitive 
sequence VPMS (Fig. 12).  
 
To study how the addition of VPMS affected hydrogel properties, we first compared the storage 
moduli (G’) of gels crosslinked with either YKNS or YKNS/VPMS (Fig. 13). For gels 
crosslinked with YKNS, the storage modulus reached 3200 Pa after 5 minutes of gelation and 
overnight swelling under physiological conditions. However, with the addition of VPMS, the 
storage modulus significantly dropped to 2200 Pa after 10 minutes of gelation and overnight 
swelling. This significant decrease in the rigidity of the scaffold was also confirmed with 
swelling ratio studies. After subjecting gels to swelling for 24 hours under physiological 
conditions, we calculated the swelling ratios of YKNS and YKNS/VPMS gels based on the 
theoretical dry weight (5 mg). Consistent with the storage moduli data, upon the addition of 
VPMS, 𝑄𝑄𝑚𝑚significantly increased from 28.5 to 32.0 after 24 hours of swelling under 
physiological conditions.  
 
3.2 ADSCs survival was improved in hydrogels prepared with YKNS/VPMS 
PEG-VS hydrogels with the same solid concentrations, but crosslinked with different peptide 
sequences, exhibit significantly different mechanical properties. Before co-encapsulating 
follicles with ADSCs, we first tested the survival of ADSCs only to assure that early stage 
follicles can receive potential support from the surviving ADSCs. We hypothesized that follicles 
need external support during early days of development in vitro, before reaching autonomy at 





To examine the survival of ADSCs in YKNS and YKNS/VPMS gels, we performed cell viability 
test on Day 7 (Fig. 14). ADSCs appeared to survive better in YKNS/VPMS gels. After counting 
the number of live and dead cells, we did not see any difference in the number of dead cells 
between the two conditions. However, a slight higher number of live cells were observed in 
YKNS/VPMS gels, indicating that the lower storage modulus of YKNS/VPMS gels may be 
beneficial to ADSCs initial survival. 
 
3.3 Follicle survival, growth and maturation 
Likely due to the improved survival of ADSCs, we observed a higher survival rate, a better 
growth, and a more successful maturation of follicles co-encapsulated with ADSCs in 
YKNS/VPMS. To focus on the effect of ADSCs on survival of the follicles at different 
developmental stages, we divided follicles into 3 groups as follows: <90 µm, 90 – 110 µm, and 
>110 µm.  
 
Of all follicles starting below 90 µm, none survived in the YKNS gels compared to a 33.3% 
survival in YKNS/VPMS gels after 12 days of culture (Fig. 15). For late primary and early 
secondary follicles starting between 90 – 110 µm in diameters, 81.8% of these follicles survived 
in YKNS/VPMS gels (Fig. 16) compared to a significantly lower 14.3% in YKNS gels. A similar 
trend was also observed for follicles starting larger than 110 µm in diameters. In YKNS/VPMS 
gels, 62.5% of the follicles survived in YKNS/VPMS gels (Fig. 16) compared to a 42.1% 
survival rate in YKNS gels (Fig. 15).  
 
In addition to the greater survival rates of follicles cultured in YKNS/VPMS gels, we also 
observed an increase in the terminal sizes of surviving follicles. This increase in terminal size 
could explain the more successful maturation results as shown in Fig. 16. We were able to 
harvest mature oocytes that reached MII, indicating possibility of fertilization compared to only 





In this chapter, we investigated the effects of peptides sensitive to MMP-driven degradation 
(VPMS) in an established PEG-VS based hydrogel system to promote in vitro development of 
early stage follicles. Considering the necessity of additional support for the initial survival of 
small follicles, we also examined a novel source of feeder cells, ADSCs, to improve the survival, 
growth and maturation of early stage follicles (≤120 µm). Our results demonstrated that ADSCs 
can serve as feeder cells to promote small follicles development cultured in eIVFG systems. 
With the addition of VPMS, the mechanical properties, such as the stiffness of the matrix and the 
consequent swelling ratios, were significantly modified. Cultured in a softer matrix, ADSCs 
showed a slightly higher survival rate over the first 7 days of culture, when the additional ADSC-
secreted factors are more important compared to the later stages of folliculogenesis. 
Consequently, we observed improved rates of survival, growth, and maturation of follicles 
cultured in YKNS/VPMS gels.  
 
Herein, we demonstrated for the first time the improved rates of survival, growth, and maturation 
of early stage follicles using dynamic, xeno-free PEG-VS based hydrogel systems. PEG-VS 
hydrogels remain an excellent option for applications in regenerative medicines because they are 
solely proteolytic degradable, compared to some of its counterparts such as PEG acrylate which 
can be hydrolytically labile (Shikanov et al. 2011a). Apart from degradability, PEG-VS polymers 
can form hydrogels through end-linked crosslinking via MTA under physiological conditions. 
The gelation and consequently the cell encapsulating condition should be non-toxic to cells in 
order to maintain cell viability. The need to maintain cell viability during the encapsulation 
process can be contradictory to maintaining the desired physical properties. As witnessed in this 
chapter, the addition of VPMS to YKNS significantly decreased the stiffness of the 
encapsulating matrix and consequently increased the swelling ratio. However, the decreased 
mechanical properties did not adversely affect the survival and proliferation of the encapsulated 
cells. In fact, the decreased mechanical properties in return may have contributed in the 




The addition of VPMS also ensured a better survival rate of ADSCs after encapsulation. With the 
addition of VPMS, we have, for the first time, demonstrated the possibility of combining 
different mechanisms of degradation in a single matrix. The combination of plasmin-sensitive 
sequence YKNS and MMP-sensitive sequence VPMS resulted in a beneficial environment for 
both the follicles and the ADSCs. Compared to the size of a follicle and the amount of proteases 
it can secrete, the size of a single cell is an order of magnitude smaller, thus the much fewer and 
more diluted proteases. Therefore, to ensure the survival of the ADSCs, especially when the co-
encapsulated follicle is not autonomous yet before reaching ~125 µm, the addition of VPMS was 
necessary as demonstrated by our data (Fig. 14).   
 
Additionally, we tested an alternative source of feeder cells, which hold a strong potential for 
translating eIVFG to human ovarian follicle in a clinical setting. As an established source of 
mesenchymal stem cells, ADSCs are easy to derive and are less controversial compared to many 
other stem cells. Derived mainly from adipose tissues, ADSCs can be derived in a patient-
specific way, thus minimizing immune rejections. Together with the synthetic, xeno-free PEG-
VS scaffold, our reported system shows great potential for human application. Compared to 
species such as rodents, human ovarian follicles require extended culture time periods to mature 
at a much larger terminal size. Currently available eIVFG approaches such as the alginate-based 
system (Xiao et al. 2015) represent significant breakthroughs of culturing human secondary 
follicles (165.8 ± 32.3 μm) in vitro for 30 – 40 days to harvest MII oocytes. The terminal sizes of 
follicles, however, reached to 600 µm compared to ~2 mm in vivo. As alginate is not degradable 
by follicles within the culture period, the compressive forces can restrict follicle development 
after reaching 400 – 500 µm, as manifested by the two-step system (Xiao et al. 2015). Compared 
to the two-step alginate-based systems, our PEG-VS based system is proteolytically degradable 
by the follicles and the co-encapsulated supporting ADSCs. Therefore, it can better 
accommodate follicle expansion during development without exerting excessive, restricting 
compressive forces. In addition, the supports provided by the co-encapsulated ADSCs could help 
small, early stage follicles survive and grow. As those follicles are more abundant in vivo, our 
system could provide a more efficient solution to harvest mature oocytes from eIVFG systems. 
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This alternative in vitro solution does not require stromal support from patient’s native ovarian 
tissue, thus minimizing the exposure to potentially malignant cells. Aiming for the small, early 
stage follicles, this novel eIVFG system can also be applied for pre-pubertal patients who are not 
responsive to hormone stimulation.  
 
In conclusion, we demonstrated a novel eIVFG system that representing great translational 
potential to be alternative fertility preservation option for women cancer survivors. Co-
encapsulated in a xeno-free, solely proteolytic PEG-VS based scaffold, the patient-specific 
ADSCs provide necessary support for small, early stage follicle to mature in vitro. This system 
represents a more efficient alternative fertility preservation option that can be applied for all 







V. Dynamic transcription factor activity networks in response to ovarian follicle culture 
environments 




Encapsulated in vitro follicle growth systems (eIVFGs) provide unique and versatile methods for 
studying ovarian follicle biology and translational potentials for alternative fertility preservation 
options. Current culture systems support the development of individual mouse follicles from the 
secondary stage onward. However, it has been a challenge to grow smaller follicles in vitro due 
to the dissociation of the oocyte from the surrounding somatic cells. The recent works on 
developing co-culturing systems for primary follicles (Hornick et al. 2013; Tagler et al. 2012; 
Tingen et al. 2011) demonstrated the importance of additional factors, such as soluble cytokines 
and extracellular matrix components, to support the survival and development of primary 
follicles. The underlying mechanism that explains the role of these factors, however, is yet to be 
understood. Such knowledge can significantly contribute to current and future literature on 
developing xeno-free, cell-free in vitro culture systems for early stage follicles.  
 
Early stage follicle development is thought to be largely gonadotropin independent and instead 
under the control of paracrine and autocrine signals from several sources in the ovary, including 
stromal cells, macrophages, and other follicles (Peters et al. 1975). Considering the native 
mammalian ovarian environment, there is a distinct spatial and temporal dynamics that may 
influence follicle development. Primordial and primary follicles are found in vivo close to the 
rigid, collagen-dense ovarian cortex, whereas larger growing follicles are found in the interior 
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medulla, which is less rigid (Woodruff and Shea 2011). Therefore, a follicle is more likely to be 
growing itself if surrounded by other growing follicles. Indeed, as previously described, when 
co-cultured with in groups of either 5 (5X) or 10 follicles (10X), primary follicles can survive 
and grow better in vitro, compared to individually cultured ones (Hornick et al. 2013). This 
number-dependent manner of early stage follicle development is likely to be an outcome of 
multiple paracrine factors secreted in an orchestrated manner. As primordial follicle activation is 
also likely achieved with paracrine signaling, it is important to understand the identities of these 
essential paracrine signals and the mechanisms under which they regulate early stage follicle 
development in vitro.  
 
As key regulators of in vitro follicle development and maturation, paracrine cues in the 
environment trigger intracellular signaling cascades that result in up- or down-regulation of 
transcription factors (TFs) – powerful players in follicle development. Despite of the multiple 
reports on several phenotypic improvements such as follicle survival, growth, and maturation, in 
response to various co-culturing eIVFG approaches, mechanistic understanding of the 
connections between the number-dependent manner of early follicle development and follicles’ 
coordinated transcriptional response remain uncharacterized. Temporally coordinated activities 
of many TFs direct progressive changes in follicle development, necessitating the use of 
experimental methods that capture the dynamic, systems-level view of quantitative TF actions 
that lead to follicle survival or death under different environments, spanning relevant time scales. 
Herein, we described an integrated approach to quantitatively characterize the real-time dynamic 
quantification of TF activity in mouse ovarian follicles cultured in alginate hydrogels in groups 
of 5X or 10X.  
 
After transduction of follicles with a lentiviral system, we examined both qualitative and 
quantitative luciferase expression from the normalization (control) vector in the follicles 
encapsulated and cultured in vitro. TF-specific constructs were delivered to follicles in parallel. 
By using bioluminescence imaging (BLI), we evaluated the expression of four TFs associated 
with follicle development at various stages of folliculogenesis: 1) p53: an important cell cycle 
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regulator; 2) NF-κB: an anti-apoptotic nuclear factor (Karin and Lin 2002); 3) Gli: an effector in 
the hedgehog signaling pathway; and 4) HIF1: a hypoxia-induced factor. BLI provided a rapid, 
non-invasive, and sensitive method to quantify luciferase levels, and was recorded repeatedly 
from each sample to monitor dynamic activity. TRACER results were subsequently correlated 
with in vitro follicle development data and hormone and cytokine profiles. Taken together, these 
results provide an overall picture of the evolving and complex interplay of transcriptional 
networks responsible for relaying biochemical and biophysical cues to the nucleus, which in turn 
directs gene expression and the number-dependent manner of primary follicle development.  
 
2. Materials and methods 
2.1 Lentivirus and transcription factor arrays 
Lentivirus was produced by co-transfecting HEK-293T cells with previously described lentiviral 
packaging vectors (pMDL-GagPol, pRSV-Rev, PIVS-VSV-G) (Dull et al. 1998) and lentiviral 
vectors using JetPrime (Polyplus, Illkirch, France). After 48 hours, supernatants were collected 
and cell debris was spun down and removed. Viruses were concentrated using PEG-it (System 
Biosciences, Palo Alto, CA) and re-suspended in phosphate buffered saline (PBS).  
 
TF reporters consist of a specific TF response element (TRE) cloned upstream of a minimal 
thymidine kinase promoter driving the gene for firefly luciferase (FLuc) or NanoLuciferase 
(NLuc) (Fig. 17A). TF reporter specificity and sensitivity studies are referenced on the 
TRANSFAC database. Each lentiviral reporter consists of three or four repeats of a TF-specific 
binding element driving expression of luciferase.  
 
2.2 Follicle enzymatic isolation, transduction and encapsulation 
To harvest large numbers of primary follicles and to facilitate the subsequent transduction by 
lentiviruses, we used enzymatic digestion of the ovaries to isolate individual follicles. For all 
experiments, ovaries were retrieved from female F1 mice (C57B6 × CBA/J) at the age of 10 – 12 
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days. After separating from surrounding connective tissues, ovaries were briefly washed with 
fresh, warm Leibovitz's L-15 medium (L15) (Thermo Fisher) before transferring to a 30 mm dish 
containing pre-equilibrated alpha modification of minimum essential medium (αMEM) (Thermo 
Fisher) and 0.5% (v/v) Pen/Strep (Thermo Fisher). After all the ovaries were transferred, 10% 
(v/v) Liberase DH at 13 Wünsch units/mL (Sigma-Aldrich) was added and gently mixed in the 
dish. The ovaries were incubated for a total of 35 – 45 minutes, followed by 5 minutes pipetting 
to break down the enzyme-digested tissues to individual follicles. The enzymatic digestion was 
then arrested by adding 10% (v/v) fetal bovine serum (FBS) (Thermo Fisher).  
 
Immediately after the enzymatic isolation, the digest was treated as a follicle suspension and 
equally divided between transcription factors of interests. To transduce follicles, the divided 
digest was incubated with approximately 10 MOI of each TF activity-reporting lentivirus for 4 
hours in maintenance medium (MM) prior to encapsulation in 0.3% (w/v) alginate (Ingredients 
Solution, Inc., Waldo, ME, USA).  
 
Details of the encapsulation process can be found in the appendix of this dissertation. Briefly, 
healthy-looking primary follicles at 90 – 110 µm were selected from the digest and were 
encapsulated in 10 µL alginate in either groups of five (5X) or ten (10X) (Fig. 17B). Follicle-
containing alginate was dropped in 50 mM CaCl2 and 140 mM NaCl for 2 min to allow for 
complete cross-linking. The alginate beads were carefully transferred to pre-equilibrated MM to 
recover for up to 2 hours. Alginate beads were individually culture in 96-well plates, with each 
well containing 150 µL growth media (GM). Black walled 96-well plates with optical bottoms 
were used for bioluminescence measurements to minimize background and cross talk between 
wells.  
 
2.4 Luciferase production measurements 
NLuc reporters were used to measure luciferase production. Two days after follicle 
encapsulation and culture, luciferase production was measured by lysing the follicles. The 2-day 
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period is sufficient to ensure stable lentiviral gene expression. To harvest the encapsulated 
follicles, culture media was replaced by 100 µL aMEM containing 10 mIU/mL alginate lyase 
(Sigma Aldrich) for 2 minutes in the incubator. Follicles were removed from the degraded 
alginate and transferred to Nano-Glo® LCS dilution buffer (Promega) with Reporter Lysis 
Buffer (Promega). After pipetting to ensure a thorough breakdown of the follicular structures, 
Nano-Glo® Live Cell substrate was added to the lysate and luminescence was immediately 
measured using GloMax® 20/20 Single Tube Luminometer (Promega), followed by measuring 
the amount of dsDNA using NanoDropTM Spectrophotometer (Thermo Fisher). To avoid 
potential fluctuation, alginate gels were sacrificed approximately 48 hours apart and before 
changing media. Triplicates of 10X follicles were used for each time point. Normalized relative 
luminescence unit (RLU) values were calculated accordingly for each replicate.  
 
2.5 Bioluminescence imaging and measurements  
Similarly, two days after follicle encapsulation and culture, live-follicle transcription factor 
activity measurement from 5 different TF reporters (TA control, p53, NF-κB, Gli, and HIF1) 
using a PerkinElmer’s IVISTM Spectrum imaging system at the Center of Molecular Imaging 
(CMI) of the University of Michigan. Xenolight luciferin substrate (Perkin Elmer) at 630 µM 
was added to each well 10 minutes prior to imaging. Bioluminescence measurements using the 
IVISTM Spectrum was performed every 24 hours after day 2 of the culture. Every 2 days, half of 
the media (75 µL) was collected and replaced with fresh, pre-equilibrated GM containing 
luciferin after imaging.  
 
For single-cell bioluminescence, NLuc reporters were used and individual 10X gels were imaged 
using an LV200 Bioluminescence Imaging System (Olympus). To minimize the floating, gels 
were transferred to a 30 mm dish with optical bottom. Sufficient GM containing NanoGlo® Live 
Cell Substrate was transferred from the original 96-well plate to cover the gel and PBS was 
added to the surroundings to prevent evaporation. All single-cell luminescence images were 
acquired with a 5-minute exposure time and a 200 EM gain. Brightfield and luminescence 
images were merged using ImageJ (Schneider et al. 2012). Individual gels were transferred back 
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to the original 96-well plates for continuous cultures. LV200 imaging was performed every 48 
hours. Immediately after imaging, half of the media (75 µL) was collected and replaced with 
fresh, pre-equilibrated GM.  
 
2.6 Hormone measurements 
Collected media from both 10X and 5X gels were used for subsequent hormone and cytokine 
studies. Upon finishing a culture, we examined the survival of follicles in 10X and 5X 
conditions. Based on the terminal diameters, 2 wells per condition were pooled together to meet 
the minimum medium volume requirements. A sample size of 4 per time point per condition was 
analyzed for androstendione (A4), estradiol (E2) and progesterone (P4).  The hormone assays 
were performed at the University of Virginia Center for Research in Reproduction Ligand Assay 
and Analysis Core and was supported by the NSF CAREER Award (#1552580) to AS.  
 
2.7 Statistical analyses 
Statistical analyses for the luciferase production and hormone data were performed in GraphPad 
Prism 7. For luciferase production, linear regression was performed. For hormone data, two-way 
ANOVA with repeated measure and Sidak's multiple comparisons tests were performed. Values 
of p<0.05 were considered significant. TF activity data was background subtracted, normalized 
to the median TA control value and log transformed as previously described (Decker et al. 2017). 
Differences in means between time points and conditions were evaluated by fitting an empirical 
hierarchical Bayesian linear model using the limma R package (Smyth et al. 2005). False 
discovery rate correction was used on the calculated p-values (Benjamini and Hochberg 1995). A 
p-value of <0.05 was considered to be statistically significant for the TF activity measurements.  
 
3. Results 




As has been previously observed, primary follicles starting between 85 – 100 µm cultured in 
groups show a number-dependent pattern of survival and growth when cultured in vitro (Hornick 
et al. 2013). After lentiviral transduction, the pattern was preserved, indicating that the 
transduction did not affect follicle development in vitro. Similar to what has been reported, in 
10X groups, we observed a higher follicle survival rate (70%) after 12 days of in vitro culture in 
alginate, compared to a 42.9% survival rate in 5X groups (Fig. 18B). In addition to an increased 
survival rate, 10X groups also demonstrated improved follicle growth (Fig. 18 A and C). 
Morphologically, after 8 days of culture, follicles in 10X groups showed a greater overall 
increase in sizes and a greater number of follicles developed an antrum (Fig. 18A) compared to 
those cultured in groups of 5. Additionally, by Day 8 of eIVFG, average diameters of follicles in 
the 10X group reached 250.4 ± 66.4 µm (mean ± S.D.), compared to an average diameter of 
215.1 ± 63.4 µm in the 5X groups (Fig. 18C). The differences in average follicle diameters 
became more significant as the culture progressed to Day 10 (p=0.0017) and Day 12 (p<0.0001) 
(Fig. 18C). The growth and development of the transduced follicles was consistent with what has 
been established (Hornick et al. 2013) and our controls, which demonstrated that lentiviral 
transduction did not affect normal folliculogenesis and can be applied to study the activities of 
TF activities during folliculogenesis.  
 
3.2 Hormone profiles of 5X and 10X follicles evidenced the number-dependent manner of 
follicle development.  
To understand the underlying mechanism of the number-dependent development pattern of 
follicles, we measured androstenedione (A4), estradiol (E2), and progesterone (P4) secreted by 
5X and 10X follicles cultured in alginate at various time points (Fig. 19) to compare the follicle 
functional development between the groups. Overall, the concentrations of all hormones 
increased as the eIVFG progressed and follicles increased in sizes. The levels of E2 followed the 
general trend of increasing as follicle grew in the culture (Fig. 19B). We did not see any 
significant difference in E2 levels between 5X and 10X groups during the first 8 days of culture. 
However, the differences became significant on Day 10 (p=0.0002) and Day 12 (p<0.0001) of 
culture, indicating a more successful functional development of follicles cultured as groups of 
ten. The significantly higher E2 level was consistent with the much larger sizes of 10X follicles 
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on Day 10 and Day 12. The levels of P4 also followed the general trend that the concentration of 
P4 increased as average follicle diameter increased (Fig. 19C). We did not observe any 
significant difference between 5X and 10X follicles during the first 10 days of culture. On Day 
12 of eIVFG, P4 reached 26.35 ± 12.53 ng/mL, which was significantly higher (p<0.0001) than 
that in the 5X follicles (5.40 ± 3.21 ng/mL). However, we did not observe any significant 
differences in A4 levels between 5X and 10X follicles at any time point (Fig. 19A). The similar 
levels of A4 could be due to similar starting diameters of follicles in either 5X or 10X groups: 
98.7 ± 6.0 µm (10X) and 99.5 ± 6.0 µm (5X). Given the similar initial diameters, it was highly 
likely that follicles from both groups started with a similar number of theca cells that synthesize 
A4 during folliculogenesis. However, the ratio of E2/A4 was healthier in 10X follicles, which 
indicated that the granulosa cells in 10X follicles were healthier as evidenced by the significant 
increase of E2 converted from A4.  
 
Taken together, culturing primary follicle in groups also supports the functional development in 
vitro, in addition to their overall survival and growth. As indicated by the number-dependent 
survival and growth pattern, 10X follicles secreted significantly more E2 towards later time 
points of the culture, consistent with their significantly larger sizes accordingly. The significantly 
higher P4 levels in 10X follicles on Day 12 of the culture and their larger terminal sizes are 
indicative of oocyte maturation potentials.  
 
3.3 Luciferase expression from normalization vector was constant during the cultures. 
In order to quantify TF-specific report activities, we first examined bioluminescence expression 
using normalization vectors. As a result of enzymatic digestion, isolated follicles were likely to 
have fragmented basement membranes, thus allowing lentiviruses to transduce granulosa cells. 
To ensure luciferase expression by the reporter, after 2 days of culture, we applied single-cell 
bioluminescence imaging technique to examine localized luciferase expression in transduced 
follicles (Fig. 20A). As shown by the merged image in Fig. 20A, granulosa cells towards the 
peripheral of the follicles had a greater rate of the lentiviral transduction. And the luciferase 
expression was localized in the confined areas of transduced granulosa cells. To monitor the 
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stability of luciferase expression from the normalization vector, we quantified the amount of total 
DNA and the intensity of bioluminescence by lysing 10X follicles every 2 days. As expected, the 
amount of total DNA significantly decreased on Day 6 of eIVFG (p<0.0001) compared to the 
baseline level on Day 2. This decrease coincided with the time of antrum formation, when 
granulosa cells undergo apoptosis to give rise to a fluid-filled cavity. Similarly to the amount of 
total DNA, the amount of luciferase measured from lysed follicles also significantly decreased 
on Day 6. Normalized to the amount of total DNA, the amount of luciferase produced by 
transduced follicles was constant (slope of linear regression formula was not significant than 0). 
This stable expression of luciferase indicated that transduced granulosa cells were proliferating at 
the same rate as the non-transduced one, which manifested as the preserved number-dependent 
manner of folliculogenesis (Fig. 18). More importantly, this stability demonstrated the rationale 
and feasibility of using normalization vectors as baseline measurements of TF activities.  
 
3.4 Differential TF dynamic activities further reflected the number-dependent manner of 
primary follicle development in vitro.  
To investigate specific TF activities as a result of different paracrine cues in the different culture 
environments, we delivered TF-specific reporter to follicles in parallel with the normalization 
vector. It has been shown that increased binding of TFs at the TRE results in increased luciferase 
production and a proportional increase in luminescence when an excess of substrate is added 
during imaging, thus providing a quantitative measure of relative transactivation (Decker et al. 
2017). We investigated four TFs: p53, NF-κB, Gli and HIF1, to evaluate their effects on 
folliculogenesis. Background subtracted bioluminescence signals were normalized to baseline 
levels established by normalization vectors. Therefore, fluctuations observed as TF activities 
reflected the dynamic changes in the amount of specific TFs present at a given time point.  
 
As a cell cycle regulator, in normal dividing cells, p53 transiently increases in temporal 
association with checkpoints of cell cycles (Kastan et al. 1992). As cells proceed through their 
cycles, p53 fluctuates. Indeed, we observed levels of p53 fluctuating during cultures in both 5X 
and 10X groups (Fig. 21A). Additionally, the levels of p53 in 10X follicles on Day 5 of culture 
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was significantly higher (p=0.013) than on Day 4 of culture, indicating a large number of cells 
proceeding through cell cycle. This trend was consistent with the slightly larger sizes of 10X 
follicles compared to 5X ones. We did not see any significant differences of p53 levels between 
5X and 10X follicles, indicating that granulosa cells from 5X and 10X follicles were growing 
comparably on cellular levels, thus no significant differences in follicle diameters, especially 
during the first 8 days of culture.   
 
The hedgehog pathway has recently been shown to be possible markers of pre-thecal cells and 
potentially involved in inducing theca cell differentiation (Young and McNeilly 2010). 
Hedgehog genes were shown to activate glioma-associated oncogene homolog (Gli) transcription 
factor in thecal cells and are perhaps related to ovulation (Young and McNeilly 2010). 
Interestingly, the levels of Gli peaked at different time points between 5X and 10X groups. In 
10X follicles, Gli reached its peak level at Day 5 of the culture, compared to a much later Day 10 
of culture in 5X follicles (Fig. 21C). Considering the time cells take to execute the changes in 
TFs, the earlier Gli peak in 10X follicles could lead to the significant increase of P4 on Day 12 of 
culture in 10X follicles. Due to the delay for TFs to take effects, even though Gli also peaked in 
5X follicles, the much later peak did not result in a significant increase of P4 during the culture 
period.  
 
Nuclear factor‐kappa B (NF‐κB) controls the expression of gene products that affect important 
cellular processes, such as cell survival, cell cycle, and apoptosis (Yeung et al. 2004). 
Transcriptionally active NF‐κB has been identified as an inhibitor of apoptosis (Karin and Lin 
2002). Interestingly, we observed an increase of NF‐κB levels in 10X follicles on Day 5 of 
culture, compared to a much later peak of NF‐κB in 5X follicles on Day 8 (Fig. 21B). Taken 
together with the antrum formation on/around Day 6 of eIVFG, we hypothesized that hypoxia as 
a result of cell proliferation in follicles could lead to the differential antrum formation rates 




We subsequently examined the dynamic activities of hypoxia-inducible factor-1 (HIF1), together 
with NF‐κB (Fig. 21D). Levels of HIF1 in 10X follicles significantly increased (p=0.013) on 
Day 6 of culture, when antrum formation is about to happen. Interestingly, HIF1 peak happened 
1 day later than the peak of NF‐κB in the same group of follicles, indicating the hypoxic stress 
on follicles as a consequence of cell proliferation. The hypoxic stress, in return, forced a portion 
of granulosa cells to undergo apoptosis to form antrum, thus the more significant differences in 
subsequent follicle survival and growth after the first 6 days of culture (Fig. 18 B and C). The 
consequences of apoptosis were also observed in the amount of total DNA and luciferase 
expression data (Fig. 20 B and C), as both values significantly decreased as cells undergoing 
apoptosis during antrum formation. Yet, the normalized luciferase production value remained 
constant even at this interesting time point, indicating that both transduced cells and non-
transduced cells underwent apoptosis at the same portion. This implication further confirmed that 
lentiviral transduction did not affect normal cellular behaviors.  
 
Interestingly in 5X follicles, the peak levels of NF‐κB and HIF1 both happened on Day 8. The 
overlap of the counter-acting effects of TFs could offset each other, thus resulting in a much less 
successful attempt of follicles to form antrum during eIVFG. Indeed, we did not observe as 
prominent antrum formation in 5X follicles. Possibly due to this reason, 5X follicles 




We have, for the first time, demonstrated the application of a lentiviral gene delivery system to 
mouse ovarian follicles to study the dynamic processes of folliculogenesis. The proposed 
approach investigated the dynamic activities of TFs during folliculogenesis and established their 
roles in the growth of early stage ovarian follicles in vitro. The study of the synchrony between 
the quantity and temporal distribution of TFs helped provide insights to the number-dependent 
manner of early stage follicles as a result of differential paracrine cues in the culture 
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environments. This knowledge may be used for developing xeno-free, cell-free culture systems 
as alternative fertility preservation options.  
 
The lentiviral transduction of ovarian follicles did not affect any cellular behaviors, thus serving 
as a powerful tool to probe for underlying mechanisms of the number-dependent manner of 
primary follicle development in vitro. By delivering in parallel TF-specific reporters with 
normalization vectors, we were able to monitor the dynamic activities of selected TFs (p53, NF-
κB, Gli, and HIF1) as a result of different paracrine cues in the culture environment. Our results 
supported that folliculogenesis is a carefully orchestrated event. Better coordinated TF quantity 
and temporal pattern in 10X follicles implied greater survival rate and better growth and 
functional development, compared to 5X follicles. These phenotypical differences between 
conditions were subsequently evidenced by monitoring follicle diameters and measuring 
hormones in the culture media.  Taken together, the incorporation of TRACER provides a 
method for non-invasive and dynamic quantification of signaling pathways when investigating 
mechanisms.  
 
Key factors and their roles during folliculogenesis have been identified and established using the 
latest developments in molecular biological technologies. The p53 family proteins have been 
shown to be involved in regulating granulosa cell function and oocyte quality and in protecting 
the fidelity of female germ cells during meiotic arrest and embryonic implantation (Hu et al. 
2011; Liang et al. 2013; Makrigiannakis et al. 2000). The nuclear factor-κB (NF-κB) takes part 
in the regulation of the granulosa cell fate during ovarian follicular development (Chu et al. 
2004; Wang et al. 2002). As a key player in the hedgehog signaling pathway, Gli has been 
described to be transcriptionally active in theca cells by stimulating theca cell proliferation and 
androgen biosynthesis (Spicer et al. 2009; Wijgerde et al. 2005). However, in order to capture 
the complexity of mechanistic pathways, we also need to understand the broad range of temporal 
activation profiles of TFs in response to the paracrine cues in the environments. Our approach 
provided large-scale, quantitative measurements of the dynamic activities of TFs in real time. 
And our results on p53, NF- κB, and Gli acquired from TRACER were consistent with what has 
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been previously established. More importantly, our results provided the real-time profiles of 
selected TFs during folliculogenesis, complementing current understanding of the dynamic 
activities of TFs.  
 
Oxygen tension in the culture environment also has a key role in regulating cellular behaviors. It 
is well established that hypoxia-induced factor (HIF)-1 is a key mediator of hypoxic response 
(Ferrara et al. 2003; Semenza 2002). Specifically for follicles, it has been shown that hypoxic 
condition is an integral part for the survival and growth of early secondary stage follicles in vitro 
(Makanji et al. 2014) and is essential for initiation of the antrum formation, which is consistent 
with our results. Additionally, the levels of HIF1 increased before antrum formation and 
immediately decreased afterwards, indicating that follicles were cultured in low O2 conditions 
until antrum formation and were subsequently exposed to higher O2 during antral stage. 
Consequently, the 10X follicles showed higher survival and better growth. This phenomenon 
was supported by previous studies investigating follicles cultured in hypoxic conditions (Makanji 
et al. 2014). Interestingly, the upregulation of HIF1 in our system as a potential consequence of 
NF‐κB upregulation was the opposite of what was previously observed in other cells (Walmsley 
et al. 2005). However, the difference could be due to the types of cells and the preservation of 
three-dimensional (3D) architecture of the ovarian follicles. The observed relationship in our 
study mirrored what happens in vivo when antrum forms during folliculogenesis, as hypoxic 
stress can be more prominent in a 3D setting.   
 
Collectively, our results reflected the dynamic activities of TFs in real time. Comparing TF 
activities from 5X and 10X conditions, our data suggested a critical but sometimes overlooked 
dynamic synchrony between the quantity of specific TFs and their temporal distribution. 
Compared to traditional ways of probing for TFs, TRACER provides large-scale, quantitative 
measurements of TFs in real time. Via lentiviral transduction, TRACER is non-invasive and 
bioluminescence can be monitored continuously without lysis of cells and/or termination of 
cultures. More importantly, as the TF-specific reporters are integrated to the genome of 
transduced cells, quantitative measurements acquired from TRACER reflect the transcriptionally 
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active TFs, which may be hard to differentiate by other methods. The advantages of TRACER 
can enable new approaches to probe for essential TFs as cells organize into structures. The arrays 
may also find utility for investigating mechanisms regulating normal and abnormal tissue 
growth, biomaterial design, or as a platform for screening therapeutics.  
 
In conclusion, we demonstrated a non-invasive approach to investigate the dynamic activities of 
selected TFs as a result of paracrine cues in different ovarian follicle in vitro culture 
environments. Our results agreed with what was previously established and provided additional 
important insights to the synchrony of the quantity of TFs and their temporal distribution. 
Considering the advantages of our approach, the arrays can be used for investigating numerous 








In adult females the number of ovarian follicles determines ovarian function and fertility. 
Healthy ovaries produce mature eggs and hormones that play important roles in maintaining 
fertility and female body functions. Follicles are extremely vulnerable to the environmental 
factors such as toxic drugs, pollution, radiation and aging, and cannot regenerate if damaged. 
Depletion of primordial follicles leads directly to premature ovarian failure, infertility and 
menopause. 
Novel bioengineering solutions, such as in vitro culture and maturation of immature ovarian 
follicles to obtain fertilizable eggs present an important solution to a clinical problem. Theses 
novel solutions will emerge from research into biomaterials, drug delivery technologies, and 
engineering of the follicle microenvironment. By examining multiple aspects of the in vitro 
mouse ovarian follicle environment, this dissertation provides new understanding of the 
bioengineering principles in numerous in vitro follicle culture applications and in the field of 
reproductive biology more broadly. Folliculogenesis is a carefully orchestrated event that 
requires the precise coordination of various systems and/or tissues in vivo. A better 
understanding of this complicated biological process necessitates greater integration of molecular 
and cellular mechanism behind the processes (endocrine, paracrine, and autocrine regulation). 
With mechanistic considerations (i.e., bottom-up approach), our proposed investigation of 
dynamic activity of transcription factors, the TRACER approach, to decipher folliculogenesis in 
vitro provided experimental data (top-down approach) from a high-throughput approach to 




Aiming to merge computational techniques and experimental data to uncover the mechanisms, 
TRACER provides a unique opportunity to quantitatively and dynamically probe for 
transcriptionally active transcription factors (TFs) networks. In the last two decades, there has 
been an explosion in the “omics” world, including transcriptomics, proteomics (Memili et al. 
2007; Peddinti et al. 2010), metabolomics (Revelli et al. 2009), and epigenomics (Vanselow et 
al. 2010). Microarrays also have been extensively used to study folliculogenesis in isolated 
ovaries (Hasegawa et al. 2009), follicles (Yoon et al. 2006), oocytes (Pan et al. 2005), and 
granulosa or theca cells (Skinner et al. 2008) and in untreated (Sasson et al. 2003; Sriraman et al. 
2006) or treated cell lines (Chin et al. 2002; Hernandez-Gonzalez et al. 2006; Wood et al. 2003). 
Unfortunately, most of the studies have limited themselves to identifying the most important 
gene(s) based on up- or down-regulations. These quantitative measurements acquired from static 
techniques were based on cell lysis and measurements of abundance, thus missing the dynamic 
changes over time and possibly consequent classification accuracy of the models. TRACER 
provides a distinct advantage over comparable techniques by serving as a platform to capture the 
dynamic changes of TFs. By measuring TF activities at multiple time points in a live cell assay, 
TRACER can be used to monitor continuous changes in cells and/or cultures, allowing for more 
accurate reflection of cellular and molecular processes. Together with a combination of 
analytical approaches, such as Principle Component Analysis (PCA) and Partial Least Squares 
Discriminant Analysis (PLSDA), key molecules involved in paracrine and autocrine signaling in 
the follicle can be identified in a systematic way to inform the development of universal media 
formulations to support in vitro follicle or organ culture. More importantly, construction of 
networks of interacting factors will reveal unknown relationships (or “signatures”), allowing for 
more accurate interpretation of the underlying mechanisms of complicated biological processes, 
such as folliculogenesis. With the mechanistic understanding of folliculogenesis and with the 
recent developments in the field of induced pluripotent cell that can convert adult skin cells back 
into an embryonic pluripotent stem cell, we can aim to recreate the process of de novo 
gametogenesis, restore gonadal function and fertility.  
 
Additionally, proposed networks established from TRACER can be tailored to specific time 
points during in vitro follicle culture, thus having potentials to construct dynamic models to 
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predict the impacts of different environmental insults to follicle development in vitro. We 
pioneered in this dissertation to develop a novel biomaterial-based toxicology assay to study the 
effects of environmental toxicants on follicle health. With an in vitro follicle culture environment 
in FA-IPN that mimics the in vivo, we developed an image analysis based high-throughput 
system to detect toxicity of chemicals on cultured secondary follicles using either individual 
toxicants or mixtures. Moving forward, we can incorporate TRACER to better understand the 
underlying mechanisms of toxicity to follicles, which can also help us discover and predict 
synergistic and antagonistic effects and find potential therapies to mitigate the adverse effects on 
the female reproductive system.  
 
Finally, the design of a biomimetic in vitro culture system and the application of TRACER could 
enable the translation of results from mouse models to humans to inform the development of 
fertility preservation techniques. In this dissertation, we demonstrated that adipose derived stem 
cells (ADSCs) promote early stage follicle development in vitro. With the autologous source of 
feeder cells and the xeno-free, biomimetic poly(ethylene glycol) (PEG) scaffold, our results 
showed great potential of translating to humans. Ultimately, we would like to culture human 
primordial follicles in a cell-free xeno-free environment to maturation. Looking ahead, applying 
TRACER could help us achieve this goal by serving as a powerful tool to better understand the 
bi-directional crosstalk between feeder cells and early stage follicles. By identifying key factors 
during different stages of folliculogenesis, we could supplement culture media in order to replace 
feeder cells. This advance in culture scheme will help accelerate translating knowledge we have 
learned in other animal models to human, thus providing additional fertility preservation options 
for patients regardless of their ages.  
 
Taken together, using a mouse model, this dissertation provides a new tool to better understand 
the dynamic changes of key factors in in vitro folliculogenesis. This knowledge could enable the 
translation of results from mouse models to humans: to predict the impacts of different 
environmental insults to follicle development and to inform the development of fertility 
preservation techniques. Using a systematic approach, we provided a holographic view of new 
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understanding of the bioengineering principles in numerous in vitro follicle culture applications 





Three-dimensional hydrogel-based culture to study the effects of toxicants  
on ovarian follicles 
Previously accepted as a chapter in Methods in Molecular Biology 
 
1. Introduction 
Mammalian ovaries contain a finite number of follicles. As the functional units of the ovaries, 
ovarian follicles are responsible for a female’s fertility and ovarian endocrine functions. In vitro 
follicle growth (IVFG) is an experimental tool that recapitulates key events of mammalian 
oogenesis and folliculogenesis in vivo. By monitoring follicle survival and growth, antral cavity 
formation, steroidogenesis and the ability of producing a mature egg, IVFG can serve as a 
accurate bioassay for studying essential biological processes related to female reproductive 
functions (Cortvrindt and Smitz 2002; Lenie and Smitz 2009; Peretz and Flaws 2013; Rotroff et 
al. 2013; Xu et al. 2015).  
 
Various IVFG culture systems have been developed aiming to grow follicles from an immature 
stage to fully mature and fertilizable oocytes, which have been successful in mouse, rat, bovine, 
goat, non-human primates and human (Hirao et al. 1994; Jin et al. 2010; Laronda et al. 2014; 
McLaughlin and Telfer 2010; O'Brien et al. 2003; Silva et al. 2015; Spears et al. 1994; Xiao et 
al. 2015; Xu et al. 2013b). Three-dimensional IVFG systems in particular, provide physical 
support to preserve the architecture of developing follicles and maintain oocyte-somatic cell 
connections, thus promoting survival of early stage follicles (Shea et al. 2014). Encapsulated in 
either natural biomaterials such as alginate (Brito et al. 2014; Xu et al. 2006) and fibrin-alginate 
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(Shikanov et al. 2009, 2011b) or synthetic macromers such as polyethylene glycol (PEG) 
(Shikanov et al. 2011a), ovarian follicles are cultured in in-vivo-like conditions, allowing for 
continuous morphological, genetic and biochemical sampling.  
 
An important application of IVFG is serving as a bioassay for reproductive toxicology screening. 
Safety information on new chemicals that are introduced into the US market each year is lacking 
due to the cost and time required for animal testing. Performing a complete set of regulatory tests 
for a single chemical requires thousands of animals and costs millions of dollars (Xu et al. 2015). 
IVFGs have been employed to determine how follicles are affected by drugs/their metabolites, 
and environmental factors, such as doxorubicin (DXR), organochloride pesticides (methoxychlor 
(MXC)) and environmental pollutants (7,12-dimethylbenz[a]anthracene (DMBA)). Compared to 
animal studies, IVFG represents a more simple and rapid tool that can be used to screen the 
effects of potential ovotoxic compounds on reproductive function and health (Cortvrindt and 
Smitz 2002; Stefansdottir et al. 2014; Xu et al. 2015), which can be useful to provide guidance to 
regulatory agencies as well as expectant mothers. 
 
In this chapter, we describe a fibrin-alginate based hydrogel system (Shikanov et al. 2009) that 
has been developed for IVFG. In the fibrin alginate interpenetrating network (FA-IPN) system, 
the slowly degrading alginate is biologically inert to ovarian tissue, thus providing structural 
support for the follicle. Ovarian follicles encapsulated in FA-IPN secrete plasminogen activators 
(Beers 1975; El-Sadi et al. 2013), and can therefore degrade the fibrin component of the FA-IPN. 
The semi-degradable FA-IPNs provide a dynamic mechanical environment that facilitates 
follicle outward expansion while maintaining follicle architecture. Such systems have also been 
proven to enable IVFG in larger species such as baboon (M Xu et al. 2011) and rhesus macaque 
(Macaca mulatta) (Xu et al. 2013a). The degraded fibrin appears as an optically clear ring around 
the encapsulated follicle as the follicle culture progresses (Shikanov et al. 2009, 2011b; Zhou et 
al. 2015), correlating with the health and survival of the encapsulated follicles. Furthermore, a 
calibrated addition of aprotinin, which is a plasmin inhibitor, to the culture media results in 
controlled fibrin degradation and therefore broadens the applications for this system (Zhou et al. 
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2015) to screen for potential ovotoxicity induced by drugs and/or their metabolites and 
environmental toxicants.  
 
2.  Materials 
2.1 General materials 
1. One pair of straight fine scissors, 26 mm. 
2. One pair of straight fine scissors, 24 mm. 
3. One pair of straight forceps, #5. 
4. One pair of curved forceps, #7. 
5. Dissecting microscope with a heating stage. 
6. Inverted imaging microscope with imaging software such as ImageJ. 
 
2.2 Ovarian follicle isolation 
1. First generation female hybrid offsprings of 2 inbred strains: C57BL/6JRccHsd (maternal) 
CBA/JCrHsd (paternal), 12 – 14 days of age. 
2. 70% Ethanol and dissecting mats. 
3. Dissection media (DM): Leibovitz's L-15 medium, heat inactivated fetal bovine serum (FBS), 
and Pen/Strep. 
4. Maintenance media (MM): minimum essential media α (αMEM), FBS, and Pen/Strep. 
5. Two 35 × 10 mm sterile petri dishes. 
6. One 60 × 10 mm sterile petri dishes. 
7. Center Well Dishes for IVF: use one (1) dish per each ovary. 
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8. Sterile 1.5 mL microcentrifuge tubes.  
9. Two sterile insulin syringes with 27 ½ G needles. 
 
2.3 Ovarian follicle encapsulation 
1. Dulbecco's phosphate-buffered saline 1X (DPBS, no calcium, no magnesium). 
2. Sterile alginate aliquots: Nalgin MV-120 alginate, activated charcoal.  
3. Sterile fibrinogen and thrombin aliquots 
4. Tris buffered saline (TBS) 25 mM with 0.15 M NaCl: Tris-HCl, Tris Base, and NaCl. 
5. TBS 25 mM with 50 mM CaCl2: Tris-HCl, Tris Base, CaCl2•2 H2O, and NaCl (crosslinking 
solution). 
6. Baxter Tisseel Fibrin Sealant: Sealer Protein Solution (fibrinogen, total protein: 96 – 125 
mg/mL, with synthetic aprotinin: 2250 – 3750 KIU/mL) and Thrombin Solution (human 
thrombin: 400 – 625 IU/mL with CaCl2: 36 – 44 µmol/mL).  
7. Sterile 1.5 mL microcentrifuge tubes. 
8. Center Well Dishes for IVF dishes. 
9. Steriflip conical tubes. 
10. Sterile cellulose membrane syringe filters.  
 
2.4 Ovarian follicle culture 
1. DPBS 
2. Growth media (GM): αMEM, 1mg/mL Fetuin, 3mg/mL bovine serum albumin (BSA), 5 
µg/mL insulin, 5 µg/mL transferrin, and 5 ng/mL selenium, and 10 mIU/mL recombinant human 
follicle stimulating hormone (rhFSH).  
63 
 
3. Sterile aprotinin aliquot: aprotinin, 1X DPBS. 
4. Sterile 1.5 mL microcentrifuge tubes. 
 
3. Methods 
All dissections should be performed in L15-based media (buffered for ambient air), on a 37 ˚C 
(temperature control) heated stage, and on a clean bench (laminar flow hood) to minimize 
potential contamination. Follicle isolation should take no longer than 30 minutes per ovary. For 
optimal results, keep the resected tissue outside the incubator for less than 1 hour. To minimize 
pH changes, limit exposure of αMEM-based media to ambient air.  All animals are treated in 
accordance with the guidelines and regulations set forth by the national and institutional IACUC 
protocols. 
 
3.1 Ovarian follicle isolation 
1. Prior to the beginning of the experiment, sterilize all the equipment by spraying 70% ethanol 
and air drying on the clean bench or in the laminar hood.  
2. Prepare DM by supplementing L-15 with 1% (v/v) FBS and 0.5% (v/v) Pen/Strep. Gently 
invert to mix well (see Note 1). Warm up the DM to 37 ˚C in a water bath (see Note 2). 
3. Prepare MM by supplementing αMEM with 1% (v/v) FBS and 0.5% (v/v) Pen/Strep. Gently 
invert to mix well (see Note 3). Prepare IVF dishes with 1 mL of MM in the center ring and 3 
mL of MM in the outer ring. Utilize one IVF dish for each isolated ovary. In addition, prepare 
another 35 mm dish with 1 mL of MM. Pre-equilibrate all the dishes for 20 minutes in the 
incubator prior to the beginning of the isolation. 
4. Euthanize one female (12 – 14 days of age), according to the institutional IACUC-approved 
protocols. Remove both ovaries from the animal. In order to assure minimal damage to the 
ovaries, remove parts of the oviduct and uterus around the ovary as well. Place roughly dissected 
ovaries into a 35 mm dish with DM. 
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5. Use a dissecting scope and insulin syringes to separate the ovaries from uterus, fat pad and 
bursa (Fig. 22A) by placing one needle at the intersection of the bursa and the oviduct to anchor 
the reproductive tract in place, and dissecting with the other needle. Place the second needle 
directly next to the first but only grip the thin membrane of the bursa. Carefully nick the bursa to 
expose the entire ovary. Transfer clean ovaries using curved forceps or a pipette with a blunt tip 
(Fig. 22B) into the 35 mm dish with pre-equilibrated MM.  If using forceps, try to not squish or 
damage the ovaries by applying excessive force. Repeat this process for both ovaries. Transfer 
one ovary to a 35 mm dish containing warm MM and place it in the incubator. Keep the other 
ovary in DM and start follicle isolation (Xu et al. 2006).  
6. Set a timer for 30 minutes. Start isolating follicles by using two Insulin syringes with 27 ½ G 
needles. With one syringe in your non-dominant hand, anchor the ovary to the bottom of the 
dish. And with a syringe in your dominant hand, gently tease and “flick” individual follicles 
from the ovary (Fig. 23A). Try to remove most of surrounding ECM without puncturing the 
follicle. Dissect out as many follicles as possible within the 30 minutes. Transfer intact isolated 
secondary follicles (120 – 135 µm in diameters, 2 – 3 layers of granulosa cells) to the outer ring 
of an IVF dish (Fig. 23B and 23C) with MM. When transferring, use a P10 pipette to carefully 
pick up isolated follicles with minimum media. To avoid follicles sticking to the walls of the 
same pipette tip and/or to each other, aspirate a little media first to the very end of the tip and 
while aspirating the follicles, alternate between media and each follicle. When expelling the 
follicles into the outer ring of the IVF dish, use a sweeping motion such that the follicles in the 
tip will end up at different spots to avoid sticking to each other (see Note 4).  
7. Repeat steps 3.1.1 – 3.1.6 for the remaining ovaries to complete the isolation. 
 
3.2 Ovarian follicle encapsulation (see Note 5) 
1. The alginate component of the FA-IPN is Nalgin MV-120 sodium alginate. To prepare sterile 
alginate aliquots (see Note 6), dissolve alginate in deionized water at a concentration of 0.1% 
(w/v) (see Note 7). Add activated charcoal [0.5 g charcoal/(g alginate)] to the alginate solution to 
remove organic impurities. Stir the mixture at room temperature for 15 minutes and let settle 
overnight. Following the charcoal treatment, sterile filter alginate solution through 0.20 µm fast 
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vacuum filtration units. Transfer the sterile alginate solution into Steriflip conical tubes to 
lyophilize. Aliquot the lyophilized sterile alginate into sterile 1.5 mL microcentrifuge tubes. One 
day before follicle isolation, reconstitute the sterile alginate aliquot with 1X DPBS to achieve 
0.8% (w/v). Leave in the laminar hood overnight to completely dissolve (see Note 8). On the day 
of experiment, vortex the alginate solution for 30 seconds to thoroughly mix. Briefly centrifuge it 
afterwards to prevent microbubbles.  
2. Prepare 25 mM TBS with 0.15 M NaCl by dissolving 3.5618 g of Tris-HCl, 0.2786 g of Tris 
Base, and 8.7750 g of NaCl in 1 L of deionized water. Titrate pH to 7.4 at room temperature. 
Sterile filter a proper amount of the solution before use.  
3. Prepare the fibrinogen according to kit instructions (see Note 9). First, reconstitute fibrinogen 
to 100 mg/mL (total protein) with the provided Fibrinolysis Inhibitor Solution containing 3000 
KIU/mL aprotinin. Then, dilute the reconstituted fibrinogen down to 50 mg/mL with additional 
25 mM TBS with 0.15 M NaCl. Aliquot the diluted fibrinogen to sterile 1.5 mL microcentrifuge 
tubes as 100 µL/tube. Reconstitute thrombin to 500 IU/mL in the 40 µmol/mL CaCl2 solution 
provided in the kit. Aliquot 50 µL/tube thrombin to sterile 1.5 mL microcentrifuge tubes (see 
Note 10). 
4. Prepare 25 mM Tris buffered saline (TBS) with 50 mM CaCl2 as the crosslinking solution. To 
make 1 L of this solution, dissolve in the deionized water the following: 3.5618 g of Tris-HCl, 
0.2786 g of Tris Base, 7.3505 g of CaCl2•2 H2O (adjust this amount if using anhydrous CaCl2), 
and 2.9220 g of NaCl (see Note 11). Titrate pH to 7.4 at room temperature. Sterile filter the 
solution prior to use.  
5. After all the isolated follicles are transferred to MM (see Note 12), thaw fibrinogen and 
thrombin aliquot(s) based on the number of follicles isolated. To prepare fibrinogen/alginate 
solution (FA) for encapsulation, mix fibrinogen (50 mg/mL), 0.8% alginate MV (vortex prior to 
use), and 1X DPBS at 1:1:2 ratio (see Note 13). Pipette up and down to thoroughly mix (see 
Note 14). It is normal if the mixed solution appears milky. Dilute thrombin stock solution with 
sterile solution of 25 mM TBS with 50 mM CaCl2 to reach a final concentration of thrombin at 
25 mg/mL. Transfer this working thrombin solution to the inner ring of a new IVF dish. In the 
outer ring, put a droplet of ~10 – 20 µL of FA as the washing droplet. Prepare another 100 µL of 
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FA droplet at a different spot in the outer ring of the same IVF dish as the encapsulating droplet 
(Fig. 24) (see Note 15). 
6. Inspect the follicles meant for encapsulation under 50X – 80X magnification. Use the 
following criteria to identify healthy follicles: 1) 2 – 3 layers of granulosa cells; 2) in the right 
size range; 3) with no separation between the oocyte and granulosa cells; 4) have round oocytes.  
Some theca cells or extra extracellular matrix are fine (see Note 16).  
7. Using a dissecting scope, carefully pick up a good follicle using a P10 pipette with minimum 
media and transfer this follicle to the wash droplet (Fig. 24A). Gently pipette it up and down to 
remove excess media from the follicle before transferring it to the encapsulating droplet (see 
Notes 17 and 18). Work quickly because the FA solution is not viscous enough to prevent 
follicles settling to the bottom of the dish. If the follicle falls through the droplet of FA solution, 
it will be difficult to pick it back up and encapsulate because follicles tend to stick to the plastic.  
8. After transferring the follicle to the encapsulating droplet, use a P10 pipette set to 7.5 µL. 
First, gently fill about half of the tip (~3.5 µL) with FA. Then, aspirate the follicle and complete 
the rest of the 7.5 µL with more FA.  
9. Slowly expel the FA/follicle from the tip (at a ~45˚ angle over the thrombin/Ca2+ solution), so 
it hangs like a drop from the end of the tip (Fig. 24B).  Very gently touch the very bottom of the 
drop to the thrombin/Ca2+ solution to form FA-IPN bead (see Note 19). Watch the position of the 
encapsulated follicles (Fig. 25B and 25C) before the beads are fully crosslinked and turn opaque 
(see Note 20). Sometimes the beads may be empty (Fig. 25A) as follicles may get stuck in the 
pipette tips. If the pipette tip touches the crosslinking solution while dropping the bead, the bead 
may end up with a hole (Fig. 25D).  
10. Allow the bead to crosslink for 2 minutes (see Note 21). In the meantime, repeat steps 3-5 
with the remaining follicles. Transfer fully crosslinked beads (Fig. 25C) to the 60 × 10 mm dish 
containing pre-equilibrated MM using a pair of curved forceps (Fig. 25D) (see Note 22). 
11. Use a new 10 µL tip for each encapsulation – this prevents follicles sticking to the used tip 
and the possibility of calcium blocking the tip that accidentally comes in touch with the 
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crosslinking solution. Also, changing the tips will help prevent potential cross-contamination 
during encapsulation and will help maintain a healthy culture. 
12. Alternate between the IVF dishes with isolated follicles. Keep only 1 IVF dish outside the 
incubator for no longer than 10 minutes (see Note 23). Even though not all of the follicles from a 
specific IVF dish will be encapsulated in one round, put the dish back to the incubator to let the 
MM re-equilibrate. In the meantime, move on to a different dish to continue encapsulation. 
Repeat steps 3.2.5 – 3.2.11 until all the isolated follicles have been encapsulated and all the 
beads are transferred to the 60 × 10 mm dish with pre-equilibrated MM (see Note 24). Count the 
number of beads and write the number on the lid.  
 
3.3 Ovarian follicle culture 
1. Mouse ovarian follicles are cultured in αMEM-based GM. To make GM, supplement αMEM 
(see Note 5.24) with 10 mg/mL Fetuin, 3 mg/mL BSA, 5 µg/mL insulin, 5 µg/mL transferrin, 
and 5 ng/mL selenium. Then, sterile filter the solution using 0.2 µm cellulose acetate syringe 
filter. Add 10 mIU/mL rhFSH and invert gently to mix (see Notes 25, 26, and 27). 
2. To prepare aprotinin aliquots, calculate the amount of aprotinin using the information 
provided by the supplier (see Note 28). According to the total amount in the container, dissolve 
all the powder in sterile DPBS to obtain a concentration of 1 TIU/mL. Aliquot this stock solution 
as 50 or 100 µL aliquots and store at -20 ˚C (see Notes 29 and 30).  
3. Count the number of beads by summing the numbers from step 12 in 3.2. Based on the total 
number of the follicles, calculate the desired volume of GM: V (GM) = the number of follicles × 
100 µL × 105% (5% more for evaporation). Equilibrate the GM in a dish. Prepare 96-well plates 
as in Fig. 26. The center wells of the plate should be filled with GM (100 µL/well), 5 wells in 
each row, 3 rows in total. All the other wells should be filled with sterile DPBS (100 µL/well) to 
minimize evaporation. Transfer the plates into the incubator to equilibrate.  
4. After all the plates are equilibrated, use curved forceps to carefully transfer one bead to each 
well of GM in the 96-well plates. Every 2 days, after completing the imaging of the cultured 




3.4 Optimal aprotinin concentration determination 
The degraded fibrin appears as an optically clear ring around the encapsulated follicle, which can 
be used as a surrogate for toxicant screening. To employ the optical clearance due to fibrin 
degradation, we have identified the range of aprotinin that maximized the control of fibrin 
degradation without affecting follicle growth. Suboptimal concentrations of aprotinin (less than 
0.01 TIU/mL) resulted in uncontrolled fibrin degradation before ovotoxic effects could take 
place (Shikanov et al. 2011b; Zhou et al. 2015).  Since fibrin gels contract in vitro (Huang et al. 
2005), concentrations above 0.1 TIU/mL additionally lead to follicle death due to the inability to 
degrade fibrin and expand in condensed FA-IPN (Shikanov et al. 2011b). For the 12.5 mg/mL 
fibrin concentration in the FA-IPN, optimal aprotinin concentration is between 0.025 and 0.05 
TIU/mL (Zhou et al. 2015). Aprotinin concentrations in this range slow down fibrin degradation 
and allow fibrin to be present at later time points to serve as the surrogate reporter for follicle 
health.  
 
3.5 Follicle imaging and analyses 
Image the cultured follicles every 2 days before changing the media. Turn on the imaging 
microscope and set up the imaging software. Position the first 96-well plate with follicles onto 
the microscope. First, use a lower magnification (e.g. 5X) to find the first bead in the first row. 
Then, record and measure the fibrin degradation ring around the follicle at 5X. Once you locate 
the bead in the well, switch to a higher magnification (e.g. 20X) to acquire an image of the 
follicle. Proceed to image all the follicles in the plate. Make sure the imaging does not take 
longer than 10 minutes; otherwise, place the plate back to the incubator and return to it 30 
minutes later to let the GM re-equilibrate (see Note 31).  
 
Follicle growth in FA-IPN can be monitored via imaging every other day (Fig. 27). Follicle 
morphology can be examined with a 20X objective (Fig. 27 A-D). To quantitatively measure 
follicle growth in FA-IPN, draw 2 orthogonal lines using ImageJ from basement membrane to 
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basement membrane across the oocyte (Fig. 27A insert), calculate the average of the two 
measurements for each follicle and generate a growth curve (Fig. 27E). Once the follicles reach 
300 µm in diameter (Qu et al. 2015), in vitro follicle maturation (IVFM) can be performed to 
evaluate oocyte quality (Xu et al. 2006). The oocytes were considered to be in metaphase I (Fig. 
27F-1), if neither the germinal vesicle (Fig. 27F-2) nor the first polar body was visible. If a polar 
body was present in the perivitelline space, the oocytes were classified as metaphase II (Fig. 
27F). Fragmented or shrunken oocytes were classified as degenerated and were discarded (Fig. 
27F-3). Healthy, competent oocytes from follicles cultured in FA-IPN should resume meiosis to 
metaphase II (MII) stage with 1 polar body present in the perivitelline space.  
 
3.6 Follicles in FA-IPN for toxicology tests 
We have demonstrated how the FA-IPN could be applied to test the ovotoxic effects of an 
anticancer drug doxorubicin (DXR) (Zhou et al. 2015). Follicles cultured in FA-IPN with 
aprotinin-controlled fibrin degradation can serve for in vitro screening of environmental 
toxicants such as 7,12-dimethylbenz[a]anthracene (DMBA) that has been previously shown to be 
ovotoxic (Igawa et al. 2009). To evaluate the effects of DMBA in our system, DMBA was 
dissolved in DMSO as a stock solution and was then further diluted with GM to reach a final 
concentration of 75 nM and 12.5 nM based on previous report (Igawa et al. 2009). The final 
concentration of DMSO in GM was kept at 0.5% (v/v) (Zhou et al. 2015). Follicles were treated 
with DMBA in GM on days 0, 2, and 4. When treating follicles encapsulated in FA-IPN with 
12.5 nM DMBA, follicles affected by DMBA exposure showed little fibrin degradation (Fig. 
28B) compared to untreated healthy follicles in the control condition (Fig. 28A). Quantification 
of fibrin degradation could also be applied as previously reported (Zhou et al. 2015). To confirm 
our findings using the fibrin degradation as the surrogate reporter, we also examined the follicle 
morphology at a higher magnification. Indeed, follicles reached smaller sizes, presented darker 
colors and had no antrum formations (Fig. 28B insert). Therefore, fibrin degradation area can 





1. DM is buffered with HEPES for the atmospheric CO2 level and is therefore the media used for 
all the procedures and manipulations performed outside the incubator. DM can be stored at 4 ˚C 
for up to 4 weeks. 
2. Do not warm up DM in the incubator because the HEPES cannot buffer for CO2 and the media 
becomes acidic.  
3. MM is the media used to keep the isolated follicles in the incubator for all the procedures after 
isolation and before the transfer into GM. MM can be stored at 4 ˚C for up to 4 weeks.  
4. Try to keep follicles separated from each other in the media at all times to avoid them sticking 
to each other. If indeed, follicles aggregate, you can use the same approach with the needles to 
pull them apart for individual follicle encapsulation.  
5. To minimize evaporation of FA droplets, follicle encapsulation should be done at room 
temperature. If you are performing follicle isolation on a heated stage, make sure you turn off the 
heating prior to follicle encapsulation. 
6. Sterile alginate aliquots should be prepared ahead of time. The aliquots should be stored in -20 
°C until use.  
7. Aqueous solution of alginate at concentrations greater than 0.2% (w/v) results in a viscous, 
difficult to filter solution. 
8. It is important to prepare the alginate solution the day before encapsulation experiments, 
because the dissolution of alginate is slow and this step can be time consuming. 
9. If Tisseel sterile kit is unavailable, this is an alternative method to purify fibrinogen from other 
commercial sources such as Sigma.  
a) Dissolve fibrinogen powder in MilliQ H2O to reach an approximate concentration of 50 
mg/mL. The supernatant contains the desired fibrinogen solution while the pellet is 
denatured protein or other particles, thus transfer the supernatant into new tubes. 
b) While fibrinogen is dissolving, prepare the appropriate amount of TBS for dialysis. Each 
dialysis tube should comfortably hold up to 25mL of fibrinogen solution and needs to be 
dialyzed versus 4L of TBS. For example, with a flat width of 40 mm, cut the tubes to be 
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~30 cm long. Once the number of dialysis bags is determined, make a 4L solution of TBS 
for each dialysis bag by following the recipe below and titrate the pH to 7.4: 
---- 17.44g Tris HCL 
---- 2.56 g Tris Base 
---- 32.00g NaCl 
---- 0.80g KCl 
 
c) Prepare dialysis tubing (M.W. = 6,000 – 8,000 Da), making sure to wet in TBS to 
separate. Wash each bag briefly with TBS in order to make sure there are no holes. Each 
dialysis tube can comfortably hold up to 25 mL of fibrinogen solution and needs to be 
dialyzed in 4 L of TBS. Clip one end of the dialysis tubing on each bag and hold bag half 
inside large TBS beaker. 
d)  Carefully transfer fibrinogen solution into bags and clip top of bags so that no solution is 
allowed to escape. Allow this closed dialysis bag to float in the TBS solution. Cover the 
beaker to prevent evaporation. 
e) Place all TBS beakers with dialysis bags on top of stirring plates (stir at slow to medium 
speeds) and allow the dialysis to occur overnight (at least 6 hours). 
f) Carefully remove fibrinogen solution from dialysis bags and filter through 5.0 µm PVDF 
filter (EMD Millipore, Billerica, MA) to remove crude impurities. 
g) Measure the concentration of the fibrinogen solution after combining all the solutions 
using the NanoDrop 1000 spectrophotometer. Dilute the fibrinogen to desired 
concentration with sterile 25 mM TBS + 140 mM NaCl buffer if necessary. 
h) Sterile filter the diluted fibrinogen solution through 0.22 µm PES membrane filter (EMD 
Millipore, Billerica, MA).  
i) Aliquot fibrinogen solution into sterile 1.5 mL microcentrifuge tubes and store at -20 ˚C 
for short term storage (up to 1 year) and -80 ˚C for long term storage. 
10. Sterile fibrinogen and thrombin aliquots should be prepared ahead of time. Both solutions are 
stored at -20 ˚C until use. 
11. The osmolality of this solution should be 0.3624 Osm based on calculation. 
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12. Avoid leaving isolated follicles in MM for longer than 2 hours: follicles tend to stick to the 
plastic. If follicles stuck to the plastic, try to lift the follicle from the bottom of the dish by 
pipetting up and down. Avoid excessive shear forces which may lead to basement membrane 
damage. 
13. Concentrations of the encapsulating matrix can be adjusted to fit a specific application by 
changing the concentrations of alginate in the range between 0.125% – 0.8%, fibrinogen 1 – 75 
mg/mL, and thrombin 1 – 500 mg/mL. For example, if a hydrogel of interests is with final 
concentrations of 0.5% alginate and 12.5 mg/mL fibrinogen, mix 50 mg/mL fibrinogen with 1X 
DPBS and 1% alginate at 1:1:2 ratios.  
14. Avoid vortexing this mixture: fibrinogen can get foamy. Pipetting up and down should be 
used to mix.  
15. Practice making empty beads without follicles to optimize the angle and speed of extrusion  
16. This step is very critical to obtaining follicles for a successful study. Only healthy appearing 
and undamaged follicles should be encapsulated. Keep multiple IVF dishes so you can alternate 
them in and out of the incubator to avoid lengthy exposure to ambient conditions. 
17. Excessive remaining media can affect the crosslinking of FA-IPN, because of the dilution 
effect. Minimize the media uptake when transferring follicles. 
18. Keep an eye on the wash droplet: change as needed if it gets pink due to the remaining media 
when transferring follicles. 
19. When touching the calcium solution with the FA droplet, avoid the tip of the pipette touching 
the solution to prevent leaving a “hole” in the final FA-IPN bead (Fig. 26D).  
20. To help better keep the follicles towards the center of the beads (Fig. 26), practice with some 
less-than-ideal follicles first to adjust how much of the 7.5 µL to take before taking up the target 
follicles.  
21. The 50 mM concentration of CaCl2 causes very fast gelation of the alginate. For a 7.5 µL 
bead, exposure to crosslinking solution for 2 minutes is sufficient for complete gelation.  
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22. When multiple FA-IPNs are present in the thrombin/Ca2+ crosslinking solution, highly 
crosslinked beads appear more opaque than those that are less crosslinked (Fig. 24C). This 
optical difference may help in identifying FA-IPNs for transferring to MM (Fig. 24D) to avoid 
extended exposure of follicles to Ca2+ ions. 
23. To avoid drastic pH changes, limit the exposure of αMEM-based media such as MM and GM 
to ambient air for no longer than 10 minutes.  
24. It is necessary to leave FA-IPNs in the MM for at least 30 minutes before plating the beads 
into GM: this process allows equilibration of the alginate matrix with the media.  
25. The αMEM used for making GM should be opened in less than a month.  
26. GM can be stored at 4 °C for up to 2 weeks. 
27. If follicle isolation process is performed on a laboratory bench and/or the tissue used is 
obtained in an unsterile way, directly from an abattoir for example, add 0.5% (v/v) Pen/Strep to 
GM to prevent potential contamination during the culture.  
28. For example, for 3-7 TIU/(mg solid), apply an average of 5.5 TIU/(mg solid) to calculate the 
total amount of aprotinin.  
29. Aprotinin aliquots can be store at -20 °C for short term or -80 °C for long term storage.  
30. Do not refreeze aprotinin solution. Use a fresh aliquot every time.  
31. Plates with GM should not stay out of the incubator for more than 10 minutes at a time. 
Preferably, finish imaging all the follicles at one time to minimize the pH changes that are 
damaging to the cultured follicles. Adjust the number of wells with GM based on how long it 
takes to complete the imaging of one plate. 
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1. Introduction   
In vitro culture of mouse ovarian follicles is a powerful technique to study folliculogenesis, the 
process of follicle development, and is a means to obtain fertilizable oocytes as a potential 
fertility preservation option. Ovarian follicles are the functional units of the ovary and consist of 
an oocyte surrounded by at least one layer of granulosa cells. The somatic compartment 
synthesizes and secretes hormones necessary for the orchestration of the inter-relationship 
between other parts of the reproductive system and the central nervous system. Mammalian 
females are born with a finite pool of primordial follicles and their loss is irreversible. 
Folliculogenesis involves recruitment of primordial follicles from the resting into the growing 
pool, progressing through several developmental stages: primordial, primary, secondary, 
preantral multilayered secondary and antral. The importance of cell-cell and oocyte-cells 
interactions in a growing follicle presents various challenges for in vitro culture in traditionally 
flat (two-dimensional) cultures (Shea et al. 2014). Since the first culture of ovarian follicles was 
reported, the overall survival rate of the cultured follicles and maturation rates of the oocytes has 
steadily improved due to optimized culture media and the introduction of 3-dimensional (3D) 
culture techniques (Tagler et al. 2013). Follicle encapsulation in a 3D environment preserves the 
spherical shape of the growing follicle, from the initial stages when the follicle is only 100 μm in 
diameter to the final stages when it reaches 350 μm in diameter (Shikanov et al. 2011a).  
Maintaining 3D architecture of a growing follicle is essential to allow for antrum formation, a 
fluid filled cavity inside the growing follicle that promotes diffusion of nutrients and oxygen to 
the oocyte and the growing cells. Lastly, the preservation of the spherical shape maintains 




Previously developed 3D culture systems have used alginate and most recently a combined 
fibrin-alginate system (Dolmans et al. 2007; Shikanov et al. 2009). These systems allowed for 
mouse follicle growth and maintained follicle structure but have a limited range for controlling 
mechanical and biological properties, such as stiffness and degradation, via chemical 
modification. The non-degradable nature of alginate limits growth of follicles from large 
animals. For example, mouse follicles have to reach only 350 μm in diameter to be considered 
ready for maturation, while human follicles have to reach at least 5 mm. The growth prohibitive 
properties of alginate were demonstrated recently with a human follicle that was first cultured in 
a 3D alginate matrix, but after it reached 500 μm in diameter the alginate was removed to allow 
further expansion of the follicle in a free floating media (Xiao et al. 2015).  The ex-capsulated 
human follicles showed improved maturation rate when first grown in alginate and then removed 
from the alginate and cultured in a 2D environment to allow increasing follicle expansion (Xiao 
et al. 2015).  Therefore, a biocompatible dynamic system is needed that can be modified for 
properties such as cell-driven degradation and material stiffness, while also accommodating the 
volumetric expansion of the encapsulated follicle.   
 
We developed a 3D PEG-based system for follicle encapsulation and culture in vitro. PEG 
hydrogels have shown to support folliculogenesis and produce fertilizable oocytes (Shikanov et 
al. 2011a). The major advantage of PEG over natural hydrogel materials is the versatility of 
mechanical and biological modifications to match physiological requirements.  Crosslinking 
PEG with peptides susceptible to degradation by different proteases, such as plasmin and MMPs, 
forms tunable PEG hydrogels with cell-controlled remodeling.  Furthermore PEG hydrogels can 
be modified with bioactive peptides such as RGD to support cell adhesion and migration (Zhu 
2010). Follicle co-encapsulation with support cells, such as feeder mouse embryonic fibroblasts 
(MEF), allows for improved survival rate of mice follicles (Tingen et al. 2011).  Most 
importantly, modifications of mechanical and biological properties are performed in situ in 
physiological conditions that are not harmful to follicles. Here, we outline a method for co-
encapsulating small (100 – 120 μm in diameter) ovarian follicles with mouse embryonic 
fibroblasts within PEG hydrogels for in vitro culture. The described approach improves the 
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survival and maturation rate of the smaller follicles that do not survive in vitro when cultured 
individually or without the feeder cells.  
 
2. Materials 
2.1 General Materials 
1. One pair of straight fine scissors, 26 mm. 
2. One pair of straight fine scissors, 24 mm. 
3. One pair of straight forceps, #5. 
4. One pair of curved forceps, #7. 
5. Cell counter (automated or hemocytometer) 
6. Dissecting microscope with a heating stage. 
7. Inverted imaging microscope with imaging software. 
 
2.2 Hydrogel Precursors   
1. 8-arm polyethylene glycol vinyl sulfone (PEG-VS) (molecular weight M.W. = 40,000 g/mol). 
2. 3-arm Peptide Crosslinker: YKNS (GCYKNSGCYKNSCG, M.W. = 1663.9 g/mol). 
3. Cell adhesive peptide: RGD (GCGYGRGDSGP, M.W. = 1067.1 g/mol). 
4. Sterile 50 mM HEPES buffer: HEPES free acid, NaCl.  
5. Sterile 1.5 mL microcentrifuge tubes.  
 
2.3 Ovarian follicle isolation 
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1. First generation female hybrid offsprings of 2 inbred strains: C57BL/6JRccHsd (maternal) 
CBA/JCrHsd (paternal), 12 – 14 days of age. 
2. 70% Ethanol and dissecting mats. 
3. Dissection media (DM): Leibovitz's L-15 medium, 10% heat inactivated fetal bovine serum 
(FBS), and 0.5% Pen/Strep. 
4. Maintenance media (MM): minimum essential media α (αMEM), 10% FBS, and 0.5% 
Pen/Strep. 
5. Two 35 × 10 mm sterile petri dishes. 
6. One 60 × 10 mm sterile petri dishes. 
7. Center Well Dishes for IVF: use one (1) dish per each ovary. 
8. Sterile 1.5 mL microcentrifuge tubes.  
9. Two sterile insulin syringes with 27 ½ G needles. 
 
2.4 Cell culture  
1. Mouse Embryonic Fibroblasts (MEFs). 
2. DMEM culture media: DMEM, 10% FBS, 1% Pen/Strep.  
3. T-75 culture flask. 
 
2.5 Follicle and MEFs co-encapsulation and culture 
1. Microscopes slides: with and without 2 mm spacers. 
2. Parafilm®. 
2. Sterile 96-well plates. 
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3. 60 × 10 mm sterile petri dishes. 
4. MM. 
5. Dulbecco's phosphate-buffered saline 1X (DPBS, no calcium, no magnesium). 
6. Growth media (GM): αMEM, 1mg/mL Fetuin, 3mg/mL bovine serum albumin (BSA), 5 
µg/mL insulin, 5 µg/mL transferrin, and 5 ng/mL selenium, and 10 mIU/mL recombinant human 
follicle stimulating hormone (rhFSH). 
7. 0.25% Trypsin/EDTA. 
8. Sterile 1.5 mL Centrifuge tubes. 
9. Sterile 15 mL conical tubes. 
 
3. Methods (see Fig. 29 as an overview)  
3.1 PEG precursor calculation – to be completed the day before the experiment 
For follicles co-encapsulated with MEFs cells, the PEG condition we use is 5% 8-arm PEG-VS 
modified with 0.5 mM RGD crosslinked with YKNS. Each follicle is encapsulated in 10 µL gels 
and based on the number of isolated follicles the total volume of the gel (𝑉𝑉𝑡𝑡𝑡𝑡𝑡𝑡) can be calculated. 
Usually, we first estimate the amounts of PEG precursors (𝑚𝑚100) in 100 µL of gel and then 
calculate the minimal amounts needed to reach the total final volume. Based on how much is 
weighed exactly (𝑚𝑚𝑤𝑤𝑤𝑤𝑤𝑤𝑤𝑤ℎ𝑤𝑤𝑑𝑑), we adjust the volume of HEPES buffer needed to dissolve all the 
precursors. For all calculation, the stoichiometric ratio should be 1:1 between the VS groups 
available to crosslink on PEG and the functional groups (SH) on the crosslinker (YKNS).  
 
For the specific encapsulation condition in this chapter: 5% 8-arm PEG-VS modified with 0.5 
mM RGD crosslinked with YKNS, in 100 µL gel, follow the steps below: 
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1. To make, 100 µL of a 5% PEG gel, first calculate the mass of PEG powder needed to make 
that volume: 𝑚𝑚100 (𝑃𝑃𝑃𝑃𝑃𝑃) =  
5
100
× 100 𝜇𝜇𝜇𝜇 × 1 𝑚𝑚𝑤𝑤
𝜇𝜇𝜇𝜇
= 5 𝑚𝑚𝑚𝑚, where 5
100
 is 5% and 1 𝑚𝑚𝑤𝑤
𝑚𝑚𝜇𝜇
 is the 
assumption that the density of powder is 1.  
Based on the calculated mass of PEG, then calculate the mole number of PEG (n): n (PEG) = 
𝑚𝑚 (𝑃𝑃𝑃𝑃𝑃𝑃)
𝑀𝑀.𝑊𝑊.(𝑃𝑃𝑃𝑃𝑃𝑃)




𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚 =  0.125 𝜇𝜇𝑚𝑚𝑚𝑚𝑚𝑚 
2. Calculate the mass of RGD to modify PEG with by calculating the moles of RGD: n (RGD) 
= 0.5 × 10−3 𝑚𝑚𝑡𝑡𝑚𝑚
𝜇𝜇
× 100 × 10−6𝜇𝜇 = 0.05 𝜇𝜇𝑚𝑚𝑚𝑚𝑚𝑚, where 0.5 × 10−3 𝑚𝑚𝑡𝑡𝑚𝑚
𝜇𝜇
 is 0.5 mM of RGD in 
the gel and 100 × 10−6𝜇𝜇 is the 100 µL of the gel to prepare. 
 
Calculate the mass of RGD powder needed to add to the gel mixture to obstain 0.5 mM RGD: 
m100 (RGD) = n (RGD) × M.W. (RGD) = 0.05 µmol × 1067.1 = 53.4 µg ≈ 0.053 mg.  
3. From here, we need to calculate the number of arms on PEG that are used to react with RGD 
[n (blocked)]. Since there is only 1 L-cysteine in RGD, therefore, arms of PEG blocked by RGD 
is equal to the mole of RGD: n (blocked) = n (RGD) = 0.05 𝜇𝜇𝑚𝑚𝑚𝑚𝑚𝑚. 
4. Next, we calculate the number of arms of PEG still available for crosslinking [n (available)], 
which is the total number of PEG arms minus the ones being used for RGD modification: 
n (available) = 8 × n (PEG) – n (blocked) = 8 × 0.125 𝜇𝜇𝑚𝑚𝑚𝑚𝑚𝑚 − 1 × 0.05 𝜇𝜇𝑚𝑚𝑚𝑚𝑚𝑚 = 0.95 𝜇𝜇𝑚𝑚𝑚𝑚𝑚𝑚. 
5. Because all the available arms are used for crosslinking and there are 3 functional groups (SH 
from L-cysteine) on each YKNS molecule, therefore, the mole of crosslinker needed is: n 
(YKNS) = 1
3
× n (available) = 0.95
3
𝜇𝜇𝑚𝑚𝑚𝑚𝑚𝑚. 
Thus, the mass of crosslinker needed in 100 μL gel: m100 (YKNS) = n (YKNS) × M.W. (YKNS) 
= 0.95
3




Based on how many follicles obtained from each ovary and how many mice used, estimate the 
total volume of gel (Vtot) required for the experiment: 𝑉𝑉𝑡𝑡𝑡𝑡𝑡𝑡 = 10𝜇𝜇𝜇𝜇 × 𝑡𝑡ℎ𝑒𝑒 𝑛𝑛𝑛𝑛𝑚𝑚𝑛𝑛𝑒𝑒𝑛𝑛 𝑚𝑚𝑜𝑜 𝑜𝑜𝑚𝑚𝑚𝑚𝑚𝑚𝑓𝑓𝑓𝑓𝑚𝑚𝑒𝑒𝑓𝑓. 
It is recommended to have 10% extra volume of precursors as wash and to compensate for the 
volume loss during mixing.  
 
Based on the calculation for 100 µL of gel and the total volume of gel, estimate the minimal 
amounts (𝑚𝑚𝑚𝑚𝑤𝑤𝑚𝑚) of precursors you need to weigh: 𝑚𝑚𝑚𝑚𝑤𝑤𝑚𝑚 =
𝑉𝑉𝑡𝑡𝑡𝑡𝑡𝑡
100 𝜇𝜇𝜇𝜇
× 𝑚𝑚100.  
 
In the 100 μL gel, PEG, RGD, and YKNS are mixed at a final volume ratio of V(PEG) : 
V(RGD) : V(YKNS) = 5 : 1 : 4. To adjust for the actual weighed amounts (𝑚𝑚𝑤𝑤𝑤𝑤𝑤𝑤𝑤𝑤ℎ𝑤𝑤𝑑𝑑) of 
precursors, use the following calculation to adjust for the amount of HEPES buffer to be added 


















Solve for 𝑉𝑉0 in the above equations: 𝑉𝑉0 is the amount of sterile HEPES buffer you need to 
dissolve each tube of powder prior to mixing.  
 
To form the gel, dissolve PEG and RGD individually first in sterile HEPES buffer and mix PEG 
and RGD solutions at a ratio of 5:1 and incubate at room temperature in ambient air for 15 mins. 
Then, add YKNS to the PEG/RGD mixture to reach the final volume ratio of V(PEG) : V(RGD) 
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: V(YKNS) = 5 : 1 : 4. Incubate this precursor mixture at 37 ºC in ambient air and gelation 
should happen in 10 minutes.  
 
Note that RGD and YKNS gradually lose their reactivity once dissolved in HEPES buffer. As a 
result, use them within 15 mins after dissolving individual components to ensure reactivity; 
otherwise, the gel may not form. 
 
3.2 Ovarian follicle isolation  
It is essential that the female mice are 12 – 14 days of age because at this age ovaries contain a 
large proportion of small follicles (100 – 120 µm diameter), which benefit the most from a co-
culture with feeder cells (Tagler et al. 2012) (Fig. 30A – C).  All dissections should be performed 
in L15-based media (buffered for ambient air), on a 37 ˚C (temperature control) heated stage, 
and on a clean bench (laminar flow hood) to minimize potential contamination. Follicle isolation 
should take no longer than 30 minutes per ovary. For optimal results, keep the resected tissue 
outside the incubator for less than 1 hour. To minimize pH changes, limit exposure of αMEM-
based media to ambient air.  All animals are treated in accordance with the guidelines and 
regulations set forth by the national and institutional IACUC protocols. 
 
1. Prior to the beginning of the experiment, sterilize all the equipment by spraying 70% ethanol 
and air drying on the clean bench or in the laminar hood.  
2. Prepare DM by supplementing L-15 with 1% (v/v) FBS and 0.5% (v/v) Pen/Strep. Gently 
invert to mix well (see Note 2). Warm up the DM to 37 ˚C in a water bath (see Note 3). 
3. Prepare MM by supplementing αMEM with 1% (v/v) FBS and 0.5% (v/v) Pen/Strep. Gently 
invert to mix well (see Note 4). Prepare IVF dishes with 1 mL of MM in the center ring and 3 
mL of MM in the outer ring. Utilize one IVF dish for each isolated ovary. In addition, prepare 
another 35 mm dish with 1 mL of MM. Pre-equilibrate all the dishes for 20 minutes in the 
incubator prior to the beginning of the isolation. 
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4. Euthanize one female (12 – 14 days of age), according to the institutional IACUC-approved 
protocols. Remove both ovaries from the animal. In order to assure minimal damage to the 
ovaries, remove parts of the oviduct and uterus around the ovary as well. Place roughly dissected 
ovaries into a 35 mm dish with DM. 
5. Use a dissecting scope and insulin syringes to separate the ovaries from uterus, fat pad and 
bursa by placing one needle at the intersection of the bursa and the oviduct to anchor the 
reproductive tract in place, and dissecting with the other needle. Place the second needle directly 
next to the first but only grip the thin membrane of the bursa. Carefully nick the bursa to expose 
the entire ovary. Transfer clean ovaries using curved forceps or a pipette with a blunt tip into the 
35 mm dish with pre-equilibrated MM.  If using forceps, try not to squish or damage the ovaries 
by applying excessive force. Repeat this process for both ovaries. Transfer one ovary to a 35 mm 
dish containing warm MM and place it in the incubator. Keep the other ovary in DM and start 
follicle isolation (Xu et al. 2006).  
6. Set a timer for 30 minutes. Start isolating follicles by using two Insulin syringes with 27 ½ G 
needles. With one syringe in your non-dominant hand, anchor the ovary to the bottom of the 
dish. And with a syringe in your dominant hand, gently tease and “flick” individual follicles 
from the ovary. Try to remove most surrounding ECM without puncturing the follicle. Dissect 
out as many follicles as possible within the 30 minutes. Transfer intact isolated secondary 
follicles (100 – 120 µm in diameters, 1 – 2 layers of granulosa cells) to the outer ring of an IVF 
dish with MM. When transferring, use a P10 pipette to carefully pick up isolated follicles with 
minimum media. To avoid follicles sticking to the walls of the same pipette tip and/or to each 
other, aspirate a little media first to the very end of the tip and while aspirating the follicles, 
alternate between media and each follicle. When expelling the follicles into the outer ring of the 
IVF dish, use a sweeping motion such that the follicles in the tip will end up at different spots to 
avoid sticking to each other (see Note 5).  
7. Repeat steps 3.2.1 – 3.2.6 for the remaining ovaries to finish the isolation. 
8. Select follicles for subsequent encapsulation and culture. Figure 2A shows a healthy follicle at 
a correct size range with a centrally located oocyte (white arrow head) surrounded with 
granulosa cells. As the culture progresses the follicle grows and expands (Fig. 30B) and forms a 
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fluid filled cavity, antrum, (Fig. 30C, black arrow head) on day 8. Follicles that are below 100 
µm in diameter and appear darker with a punctured oocyte (Fig. 30D) do not progress during 
culture and eventually die by extruding the oocyte (black arrow, Fig. 30F). 
9. Count the number of ideal follicles for encapsulation. Ultimately, you should be able to collect 
between 20 – 30 good follicles from 1 ovary. 
 
3.3 Follicle and MEFs co-encapsulation in PEG 
1. Five days before the day of experiment, seed mouse embryonic fibroblast (MEFs) cells at 
8000 cells/cm2 in a T-75 flask or according to established lab specific protocols.  
2. Add 10 mL of DMEM (DMEM, 10% (v/v) FBS, 1% (v/v) Pen/Strep) and change media every 
other day. Ensure cells reach 80% – 90% confluency on the day of experiment.  
3. Prepare 50 mM HEPES buffer by dissolving 1.911 g of HEPES free acid and 0.776 g of NaCl 
in 90 mL of MilliQ water. If necessary, use 1N NaOH to titrate pH to 7.62 at room temperature 
such that it reaches 7.4 once warmed to 37 ºC. Add water to 100 mL and measure the pH again. 
Sterile filter prior to use.  
4. Mouse ovarian follicles are cultured in αMEM-based GM. To make GM, supplement αMEM 
with 10 mg/mL Fetuin, 3 mg/mL BSA, 5 µg/mL insulin, 5 µg/mL transferrin, and 5 ng/mL 
selenium. Then, sterile filter the solution using 0.2 µm cellulose acetate syringe filter. Add 10 
mIU/mL rhFSH and invert gently to mix. 
5. Sterilize microscope slides and accompanying strips of Parafilm® using 70% ethanol.  
6. Once dry, cover the surfaces of microscope slides with Parafilm® in a sterile environment and 
keep within reach for encapsulation (see Figure 3A). For each workload of encapsulation (see 
Note 6), you need 1 slide with 2 mm spacers (slide #1), 1 slide without (slide #2), and 2 
accompanying Parafilm® strips to cover the working surfaces on both slides.  
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7. Weigh out the proper amounts of PEG, RGD, and YKNS (see Note 7). Dissolve the PEG in 
appropriate HEPES volume as well as RGD in its appropriate volume allowing both to become 
fully dissolved in the buffer. 
8. In a 1.5 mL centrifuge tube, mix PEG solution with RGD solution at a 5:1 ratio and mix by 
pipetting up and down for 15 seconds. Incubate at room temperature in ambient air for 15 mins.  
9. In the meantime, trypsinize the cells according to established lab specific protocols or the 
following. In a sterile environment, remove all the media from the flask. Briefly rinse with 2 ml 
of DPBS and aspirate it out. Add 3 mL of 0.25% Trypsin/EDTA and incubate the cells for 3 – 5 
mins in the incubator. Check after 3 mins and gently tap the flask if necessary to help MEFs 
detaching from the bottom of the flask.  
10. After the majority (>90%) of the cells have detached from the flask, neutralize the trypsin by 
adding 3 mL of pre-warmed DMED culture media. Wash the surface twice by pipetting the 
liquid. Transfer all the liquid (~6 mL) to a 15 mL conical tube and perform cell counting.  
11. Calculate the amount of cell suspension needed to encapsulate all the follicles at a 
concentration of 2 × 105 cells/mL (see Note 8) and aliquot into 1.5 mL microcentrifuge tubes 
based on how you prepare PEG, RGD, and YKNS aliquots.  
12. Centrifuge at 200X g for 5 mins and keep warm at 37°C until use. Be sure to use cells within 
1 hour. 
13. Select 4 good follicles for encapsulation and transfer them to the center well of an IVF dish.  
14. Add the calculated amount of HEPES to dissolve YKNS and gently pipette to mix.  
15. Work quickly to remove the supernatant from a 1.5 mL tube containing cells. Add YKNS to 
the PEG/RGD mixture to reach a final ratio of V(PEG) : V(RGD) : V(YKNS) = 5 : 1 : 4. 
Resuspend the cell pellet in appropriate amount of this precursor mixture. Start a timer for 10 
mins. 
16. Work quickly to pipette 5 droplets of cell suspension in PEG precursors onto the the 
Parafilm® on slide #1: 4 encapsulating droplets of 10-μL and 1 “wash” droplet with 20 μL of 
PEG solution (see Fig. 31A).  
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17. Under the dissecting scope, use a P10 pipette to transfer 1 of the selected follicles to the 
“wash” droplet first. Pipette it up and down 5 times in the “wash” droplet to get rid of excess 
media (Fig. 31B, see Note 9).  
18. Change pipette tips and repeat step 3.3.17 until all the 4 follicles are individually 
encapsulated in each encapsulation droplet.  
19. Cover slide #1 with a Parafilm® covered slide #2. Flip the slides such that slide #1 is on top. 
Place the slides on a heating stage at 37 °C until gelation completes.  
20. Once gelation completes, gently peel apart the slides. Use a pair of curved forceps, carefully 
transfer all the gels into a 60 × 10 mm sterile petri dishes containing pre-equilibrated MM.  
21. Repeat steps 3.3.13 – 3.3.20 until all the follicles are co-encapsulated with MEFs. Use new 
Parafilm® strips every time to ensure hydrophobicity.  
22. After completing the encapsulation process, transfer the gels to 96-well plates: 1 gel per well 
containing 150 μL of GM.  
23. Incubate at 5% CO2 and 37°C for 8-12 days, replacing half of the media and imaging every 
two days. On the day of the imaging, turn on the imaging microscope and set up the imaging 
software. Position the first 96-well plate with follicles onto the microscope. First, use a lower 
magnification (e.g. 5X) to find the first well with the follicle in a gel in the first row. Once you 
locate the hydrogel and the follicle in it in the well, switch to a higher magnification (e.g. 20X) 
to acquire an image of the follicle. Proceed to image all the follicles in the plate. Make sure the 
imaging does not take longer than 10 minutes; otherwise, return the plate back to the incubator 
and resume imaging of the same plate after at least 30 minutes when GM re-equilibrates.  
24. Examine the follicle morphology with a 20X objective (Fig. 30A – F). To quantitatively 
measure follicle growth in PEG, draw 2 orthogonal lines using ImageJ from basement membrane 
to basement membrane across the oocyte, calculate the average of the two measurements for 
each follicle and generate a growth curve (Dolmans et al. 2007; Shikanov et al. 2011a; Tagler et 
al. 2013). Once the follicles reach 300 µm in diameter, in vitro follicle maturation (IVFM) can be 
performed to evaluate oocyte quality following published procedures (Dolmans et al. 2007; 





1. In this specific condition, the precursors are mixed at a ratio of V(PEG) : V(RGD) : V(YKNS) 
= 5 : 1 : 4. That is, for example, in a 100 µL gel, 50 µL of HEPES is used to dissolve PEG, 10 
µL of HEPES is used to dissolve RGD, and the remaining 40 µL of HEPES is used to dissolve 
YKNS. 
2. DM is buffered with HEPES for the atmospheric CO2 level and is therefore the media used for 
all the procedures and manipulations performed outside the incubator. DM can be stored at 4 ˚C 
for up to 4 weeks. 
3. Do not warm up DM in the incubator because the HEPES cannot buffer for CO2 and the media 
becomes acidic.  
4. MM is the media used to keep the isolated follicles in the incubator for all the procedures after 
isolation and before the transfer into GM. MM can be stored at 4 ˚C for up to 4 weeks.  
5. Try to keep follicles separated from each other in the media at all times to avoid them sticking 
to each other. If follicles do aggregate, apply the same approach with the needles to pull them 
apart for individual follicle encapsulation.  
6. Given the 10 mins gelation time, after mixing all the precursors, encapsulate no more than 4 
follicles. Once the user is more familiar with the process, the number of follicles in each 
encapsulation round can be adjusted.  
7. Depending on how fast the user can encapsulate follicles and how many follicles the user 
encapsulates every experiment, it may be beneficial to make aliquots of PEG, RGD, and YKNS 
in advance, especially if less than 1 mg of the peptides is used every time to ensure accuracy. To 
make aliquots of PEG, RGD and YKNS, dissolve appropriate amounts of PEG, RGD, and 
YKNS in sterile filtered MilliQ water with 10% glacial acetic acid to a proper concentration, 1 
mg/mL for RGD and YKNS for example. Aliquot desired amounts of each solution into tubes 
and freeze them at -20 °C. Snap freeze the tubes in liquid nitrogen before loading to a 
lyophilizer. Lyophilize until completely dry. Wrap the tubes with Parafilm® and store at -20 °C. 
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8. We use 2 × 105 cells/mL for MEFs and follicle co-encapsulation. The concentration of the 
cells is determined by the proliferation speed and nutrients consumption. MEFs are fast 
proliferating cells that, if seeded at greater concentrations, can overwhelm the culture and 
deprive the follicle from nutrients. For slower proliferating cells, greater concentrations may be 
used. Careful titration is needed when co-culturing different cells. 
9. It is essential to wash away the excessive media in the wash droplet to ensure successful 
gelation because the serum in the media interferes with and can stop the gelation from 
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Fig. 2 Aprotinin-controlled fibrin degradation. 
 
(a) Representative images of follicles encapsulated in FA-IPNs on different days of culture with 
higher magnification images of follicles in the lower right inserts. Comparison showed that 
optimized aprotinin concentration (0.025 to 0.05 TIU/mL) effectively delayed fibrin degradation 
till D8, a critical time for antrum formation. Arrow points to the fibrin degradation area 
surrounding the growing follicle. Arrow head (“<”) points to the encapsulated follicle in the FA-
IPN. Scale bar=500 µm. (b) Growth curves of follicles cultured in growth media with and 
without aprotinin. Data are shown as mean ± SEM, p < 0.05. n (total follicles, GM) = 286, n 
(total follicles, GM+Apr) = 258, n (total animals used) = 30, n (experiments) = 10 for each 
condition. (c) Representative images of in vitro follicle maturation (IVFM) results confirming 
oocyte quality from both GM (left) and GM+Apr (right) conditions. Data are shown as mean ± 




Fig. 3 Correlation of fibrin degradation and follicle health, evaluated by both manual 
calculation (M) and automated MATLAB ® program (A). 
 
(a) Representative images of a live follicle (top) and a dead follicle (bottom) in brightfield 
images and processed binary images. Scale bar = 800 µm. (b) Results from manual calculation 
(M) and automated program measurement (A) of fibrin degradation in GM+Apr condition for 
live follicles on D6. Data presented as mean ± SEM, with n = 9 in each case.  
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Fig. 4 Illustration of the HTP system.  
 
Images captured from 96-well plates are converted using  MATLAB ® program to binary 
images. After comparing the area of fibrin degradation (shown as white circles) to control 
conditions, the program will then output results of follicle health evaluated by fibrin degradation: 




Fig. 5 System validation with Doxorubicin (DXR).  
 
(a) Representative images of dose response of cultured follicles to DXR. Arrow points to the 
fibrin degradation area surrounding the growing follicle. Arrow head (“<”) points to the 
encapsulated follicle in the FA-IPN. Scale bar = 500 µm. (b) Kaplan-Meier cumulative survival 
curves for DXR treatments and control. Sample sizes for each condition [n (condition) = total 
follicles, animal used, experiments]: n (200 nM) = 69, 4, 3; n (10 nM) = 52, 3, 3; n (1 nM) = 75, 
3, 3; n (0.1 nM) = 75, 3, 3; n (0.01 nM) = 80, 3, 3; n (0.005 nM) = 92, 4, 3. (c) Representative 
images of in vitro follicle maturation (IVFM) results from survived follicles in the 0.01 nM (left) 
and 0.005 nM (right) DXR treatment group. Scale bar = 100 µm. (d) The diameters of surviving 
follicles in control conditions (GM and GM+Apr) and 0.005 nM and 0.01 nM DXR treatment 




Fig. 6 Quantitative measurements of fibrin degradation with different DXR treatments.  
 
(a) Manual calculation of fibrin degradation area; (b) Automated MATLAB® measurement of 
fibrin degradation. Data presented as mean ± SEM, n = 9, † n (GM+Apr+0.005nM DXR, dead, 





Fig. 7 Lindane concentration-dependent effects on cultured ovarian follicles.  
 
A. Representative images of lindane concentration-dependent effects on secondary follicles. 
Scale bar = 100 µm. B. Follicle survival after lindane treatments. N = 75 (control: GM), 128 
(0.25 µM), 128 (0.5 µM), 104 (5 µM). C. Follicle growth curves with lindane treatments: data 




Fig. 8 DMBA concentration-dependent effects on cultured ovarian follicles.  
 
A. Representative images of DMBA does-dependent effects on secondary follicles. Scale bar = 
100 µm. B. Follicle survival after DMBA treatments. N =75 (control: GM), 124 (6.25 nM), 128 
(12.5 nM), 54 (25 nM). C. Follicle growth curves under DMBA treatments: data presented as 
mean ± SEM. N = 52 (control: GM), 62 (6.25 nM), 50 (12.5 nM).  
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Fig. 9 Combinational effects of Lindane and DMBA on cultured secondary ovarian 
follicles.  
 
A. Representative images of Lindane and DMBA combinational effects on secondary follicles. 
Scale bar = 100 µm. B. Follicle survival under combination of Lindane and DMBA. n(control) = 
75, n(LC10s) = 102, (LC50s) = 100. C. Follicle growth under combination of Lindane and 




Fig. 10 Lindane and DMBA effects on oocyte of survived follicles.  
 
A percentage change was calculated as: 𝑝𝑝𝑒𝑒𝑛𝑛𝑓𝑓𝑒𝑒𝑛𝑛𝑡𝑡𝑝𝑝𝑚𝑚𝑒𝑒 𝑓𝑓ℎ𝑝𝑝𝑛𝑛𝑚𝑚𝑒𝑒 = 𝑡𝑡𝑡𝑡𝑤𝑤𝑡𝑡𝑡𝑡𝑚𝑚𝑤𝑤𝑚𝑚𝑡𝑡−𝑐𝑐𝑡𝑡𝑚𝑚𝑡𝑡𝑡𝑡𝑡𝑡𝑚𝑚
𝑐𝑐𝑡𝑡𝑚𝑚𝑡𝑡𝑡𝑡𝑡𝑡𝑚𝑚
. Data were 
pooled from at least 3 independent experiments in any conditions. Sample sizes were as follow: n  
= 45 (control), 38 (0.25 µM lindane), 20 (0.5 µM lindane); n = 28 (6.25 nM DMBA), 24 (12.5 




Fig. 11 Lindane and DMBA effects on secondary ovarian follicles.  
 
A. Concentration-dependent responses of lindane and DMBA on cultured ovarian follicles: data 
presented as mean ± SEM; n(0.25 µM lindane) = n(6.25 nM DBMA) = 5 cultures, n(0.5 µM 
lindane) = n(5 µM lindane) = n(12.5 nM DMBA) = n(25 nM DMBA) = 3 cultures, n(LC10s) = 
n(LC50s) = 6 cultures. B. Proposed follicle metabolisms of lindane and DMBA: summarized 
from literature (Bhattacharya and Keating 2011; Organization 1991).  
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Fig. 13 Mechanical properties of YKNS and YKNS/VPMS gels.  
 




Fig. 14 Improved ADSC survival in YKNS/VPMS gels.  
 




Fig. 15 Follicle survival, growth and maturation in YKNS gels.  
 
Sample sizes: for survival curves: n = 7 (<90 µm), 28 (90 – 110 µm), and 19 (> 110 µm); for 





Fig. 16 Follicle survival, growth and maturation in YKNS/VPMS gels.  
 
Sample sizes: for survival curves: n = 3 (<90 µm), 11 (90 – 110 µm), and 8 (> 110 µm); for 











Fig. 18 The number-dependent manner of folliculogenesis in follicles cultured in either 
groups of five (5X) or ten (10X).  
 
A. Representative images of eIVFG in 5X and 10X follicles. Scale bar = 500 µm (100 µm for 
inserts). B. Follicle survival in 5X and 10X. Sample size: n = 35 (5X) and 80 (10X). C. Follicle 





Fig. 19 Profiles of androstenedione (A4) (A), estradiol (E2) (B), and progesterone (P4) (C) 
in 5X and 10X follicles during eIVFG.  
 





Fig. 20 Bioluminescence and luciferase production from normalization vectors in 
transduced follicles.  
 
A. Representative bioluminescence images of transduced follicles to confirm luciferase 
expression. Scale bar : 100 µm. B. Quantification of the amount of total DNA during eIVFG. 
Sample size: n = 3 per time point. C. Quantification of luciferase production during eIVFG. 





Fig. 21 Dynamic activities of selected TFs (p53 = A, NF-κB = B, Gli = C, and HIF1 = D) 






Fig. 22 Isolating ovaries from surrounding tissues.  
 





Fig. 23 Follicle isolation.  
 
A: Needle positions relative to an identified follicle. Dashed circle: an identified follicle. The left 
needle is used to anchor the tissue to the bottom of the plate while the right needle is used to 
tease and “flick” the follicle away from the ovary. B: Isolated follicles under 50X. Try to keep 
isolated follicles apart to prevent them sticking back together. White arrows: example follicles; 





Fig. 24 Follicle encapsulation setup for FA-IPN.  
 
A: FA-IPN encapsulation setup with the washing droplet on the right and the encapsulating drop 
on the left. B. Dropping the FA-IPN with a follicle into the TBS solution with calcium. C. FA-





Fig. 25 Follicles encapsulated in FA-IPNs.  
 
A. Empty bead; B. Follicle encapsulated at the edge of the bead; C. Follicle encapsulated 





Fig. 26 96-well plate setup with DPBS (blue) on the outer side as humidity control and GM 






Fig. 27 Follicles in FA-IPN with aprotinin-controlled degradation are used to screen for 
toxicants in vitro.  
 
A & C: Representative images of follicles in FA-IPN on D2. Insert of A shows the 
measurements of follicle diameter: 2 orthogonal lines across the oocyte, excluding the ECM. B 
& D: Representative D10 images of live (B) and dead (D) follicles. E: Follicle growth curve in 
FA-IPN. Data are presented as mean ± SEM, with n = 30. F: Representative image of in vitro 





Fig. 28 Representative D6 images of FA-IPN application for toxicology test (12.5 nM 
DMBA).  
 
A: untreated growing follicle in the control condition, antrum outlined. B: treated and dead 





Fig. 29 General experimental outline for follicle and cell co-encapsulation, see text for 
detailed description.  
 
1) The experiment should start by extracting the ovary and isolating individual follicles which 
are then stored in an incubator for future use up to 12 hours, see “Ovarian Dissection” and 
“Follicle Isolation” steps. 2) Cells are then trypsinized from incubation flask, counted and 
centrifuged into pellets containing 100,000 cells. Cell pellets should be maintained in DMEM at 
37°C during encapsulation for no longer than one hour, see “Cell and Follicle Encapsulation”. 3) 
Resuspend cell pellet in PEG-RGD solution and add crosslinker solution only when you are 
ready to begin encapsulation, see “Cell and Follicle Encapsulation”. Using the PEG-RGD-
crosslinker cell suspension, form droplets on parafilm which will be used for 4) follicle 





Fig. 30 Evaluation of follicle survival after the encapsulation.  
 
Top row: (A) a healthy follicle on Day 0 has a diameter between 100-120 µm with centrally 
located round intact oocyte (white arrow head) surrounded by granulosa cells. (B) A healthy 
follicle grows and expands and on day 8 antrum formation(C, black arrow head) promotes 
further development. The healthy follicle will reach a diameter of 300 µm or more on Day 8 or 
10.Bottom row: (D) a non-healthy follicle has a dark complexion and the oocyte does not have a 
round shape with homogeneous color. Follicles with dark regions do not grow or expand and 





Fig. 31 Schematic of the gel preparation.  
 
A) Glass slide coated with a hydrophobic layer of parafilm. B) Hydrogel droplets (10 μl each) on 
the hydrophobic surface for follicle rinse and follicle encapsulation.  C) Image of a slide with 
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